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Abstract
The goal of Systems Biology is to understand the complex behavior that
emerges from the interaction among the cellular components. Industrial
biotechnology is one of the areas of application, where new approaches for
metabolic engineering are developed, through the creation of new models and
tools for simulation and optimization of the microbial metabolism. Although
whole-cell modeling is one of the goals of Systems Biology, so far most mod-
els address only one kind of biological network independently. This work
explores the integration of different kinds of biological networks with a focus
on the improvement of simulation of cellular metabolism. The bacterium
Escherichia coli is the most well characterized model organism and is used
as our case-study.
An extensive review of modeling formalisms that have been used in Sys-
tems Biology is presented in this work. It includes several formalisms, in-
cluding Boolean networks, Bayesian networks, Petri nets, process algebras,
constraint-based models, differential equations, rule-based models, interact-
ing state machines, cellular automata and agent-based models. We compare
the features provided by these formalisms and classify the most suitable ones
for the creation of a common framework for modeling, analysis and simula-
tion of integrated biological networks.
Currently, there is a separation between dynamic and constraint-based
modeling of metabolism. Dynamic models are based on detailed kinetic re-
constructions of central metabolic pathways, whereas constraint-based mod-
els are based on genome-scale stoichiometric reconstructions. Here, we ex-
plore the gap between both formulations and evaluate how dynamic models
can be used to reduce the solution space of constraint-based models in order
v
to eliminate kinetically infeasible solutions.
The limitations of both kinds of models are leading to new approaches
to build kinetic models at the genome-scale. The generation of kinetic mod-
els from stoichiometric reconstructions can be performed within the same
framework as a transformation from discrete to continuous Petri nets. How-
ever, the size of these networks results in models with a large number of
parameters. In this scope, we develop and implement structural reduction
methods that adjust the level of detail of metabolic networks without loss
of information, which can be applied prior to the kinetic inference to build
dynamic models with a smaller number of parameters.
In order to account for enzymatic regulation, which is not present in
constraint-based models, we propose the utilization of Extended Petri nets.
This results in a better scaffold for the kinetic inference process. We eval-
uate the impact of accounting for enzymatic regulation in the simulation of
the steady-state phenotype of mutant strains by performing knockouts and
adjustment of enzyme expression levels. It can be observed that in some
cases the impact is significant and may reveal new targets for rational strain
design.
In summary, we have created a solid framework with a common formalism
and methods for metabolic modeling. This will facilitate the integration with
gene regulatory networks, as we have already addressed many issues also
associated with these networks, such as the trade-off between size and detail,
and the representation of regulatory interactions.
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Resumo
O objectivo da Biologia de Sistemas e´ compreender os comportamentos que
resultam das complexas interacc¸o˜es entre todos os componentes celulares.
A biotecnologia industrial e´ uma das a´reas de aplicac¸a˜o, onde novas abor-
dagens para a engenharia metabo´lica sa˜o desenvolvidas atrave´s da criac¸a˜o
de novos modelos e ferramentas de simulac¸a˜o e optimizac¸a˜o do metabolismo
microbiano. Apesar de um dos principais objectivos da Biologia de Siste-
mas ser a criac¸a˜o de um modelo completo de uma ce´lula, ate´ ao momento
a maioria dos modelos desenvolvidos incorpora de forma separada cada tipo
de rede biolo´gica. Este trabalho explora a integrac¸a˜o de diferentes tipos de
redes biolo´gicas, focando melhorar a simulac¸a˜o do metabolismo celular. A
bacte´ria Escherichia coli e´ o organismo modelo que esta´ melhor caracterizado
e e´ usado como caso de estudo.
Neste trabalho e´ elaborada uma extensa revisa˜o dos formalismos de mo-
delac¸a˜o que teˆm sido utilizados em Biologia de Sistemas. Sa˜o considerados
va´rios formalismos tais como, redes Booleanas, redes Bayesianas, redes de
Petri, a´lgebras de processos, modelos baseados em restric¸o˜es, equac¸o˜es di-
ferenciais, modelos baseados em regras, ma´quinas de interacc¸a˜o de estados,
auto´matos celulares e modelos baseados em agentes. As funcionalidades ine-
rentes a estes formalismos sa˜o analisadas de forma a classificar os mesmos
pelo seu potencial em servir de base a` criac¸a˜o de uma plataforma para mo-
delac¸a˜o, ana´lise e simulac¸a˜o de redes biolo´gicas integradas.
Actualmente, existe uma separac¸a˜o entre modelac¸a˜o dinaˆmica e modelac¸a˜o
baseada em restric¸o˜es para o metabolismo celular. Os modelos dinaˆmicos
consistem em reconstruc¸o˜es cine´ticas detalhadas de vias centrais do meta-
bolismo, enquanto que os modelos baseados em restric¸o˜es sa˜o constru´ıdos a`
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escala geno´mica com base apenas na estequiometria das reacc¸o˜es. Neste tra-
balho explora-se a separac¸a˜o entre os dois tipos de formulac¸a˜o e e´ avaliada a
forma como os modelos dinaˆmicos podem ser utilizados para reduzir o espac¸o
de soluc¸o˜es de modelos baseados em restric¸o˜es de forma a eliminar soluc¸o˜es
inalcanc¸a´veis.
As limitac¸o˜es impostas por ambos os tipos de modelos esta˜o a condu-
zir a` criac¸a˜o de novas abordagens para a construc¸a˜o de modelos cine´ticos a`
escala geno´mica. A gerac¸a˜o de modelos cine´ticos a partir de reconstruc¸o˜es
estequiome´tricas pode ser feita dentro de um mesmo formalismo atrave´s da
transformac¸a˜o de redes de Petri discretas em redes de Petri cont´ınuas. No
entanto, devido ao tamanho destas redes, os modelos resultantes incluem
um nu´mero extremamente grande de paraˆmetros. Neste trabalho sa˜o im-
plementados me´todos para a reduc¸a˜o estrutural de redes metabo´licas sem
perda de informac¸a˜o, que permitem ajustar o n´ıvel de detalhe das redes. Es-
tes me´todos podem ser aplicados a` infereˆncia de cine´ticas, de forma a gerar
modelos dinaˆmicos com um menor nu´mero de paraˆmetros.
De forma a considerar efeitos de regulac¸a˜o enzima´tica, os quais na˜o sa˜o
representados em modelos baseados em restric¸o˜es, propo˜e-se a utilizac¸a˜o de
redes de Petri complementadas com arcos regulato´rios. Este formalismo e´
utilizado como base para o processo de infereˆncia cine´tica. A influeˆncia
da regulac¸a˜o enzima´tica na determinac¸a˜o do estado estaciona´rio de estirpes
mutantes e´ avaliada atrave´s da ana´lise da remoc¸a˜o de reacc¸o˜es e da variac¸a˜o
dos n´ıveis de expressa˜o enzima´tica. Observa-se que em alguns casos esta
influeˆncia e´ significativa e pode ser utilizada para obter novas estrate´gias de
manipulac¸a˜o de estirpes.
Em suma, neste trabalho foi criada uma plataforma so´lida para modelac¸a˜o
do metabolismo baseada num formalismo comum. Esta plataforma facilitara´
a integrac¸a˜o com redes de regulac¸a˜o gene´tica, pois foram abordados va´rios
problemas que tambe´m se colocam nestas redes, tais como o ajuste entre
o tamanho da rede e o seu n´ıvel de detalhe, bem como a representac¸a˜o de
interacc¸o˜es regulato´rias entre componentes da rede.
viii
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Chapter 1
Introduction
1.1 Systems Biology
The cell is the fundamental building block of life. From this basic unit,
a myriad of life forms have emerged. Systems Biology is a recent field of
study that focuses on the complex interactions that happen inside a cell. It
represents a new paradigm when compared to classical biology, as it looks at
the cell as a whole rather than enumerating its parts [40, 41].
A single cell is composed by thousands of components such as genes, pro-
teins and metabolites. These components interact in several ways, forming
complex biological networks. The behavior of the cell emerges not only from
the structure but also from the dynamics of these networks. A common anal-
ogy in the community is the functioning of a radio. It is not possible to fix a
radio, if all the parts are disassembled and we do not know how to put them
together [42].
Unlike the radio, which has its own blueprint, the design of the cell has
evolved in nature. Reverse engineering its specification involves collecting
and analyzing vast amounts of data. The rise of Systems Biology is re-
lated to the development of high-throughput technologies in the past years,
that have generated several of the so-called omics, including genomics [67],
transcriptomics [83], proteomics [25], metabolomics [24], and fluxomics [71].
These data allow the quantification of the molecular species present in the
1
Figure 1.1: Model development cycle.
cell and the reconstruction of their map of interactions. With this informa-
tion we can build models for in silico simulation. Models can also be used to
drive new experiments that will allow model refinement. Hence, the model
building cycle is an iterative process that alternates between wet and dry lab
experiments (Figure 1.1).
The synergy between computational and experimental methods, comes
from the multidisciplinary nature of this field. It requires cooperation among
researchers from several areas such as computer science, mathematics, physics,
chemistry, biology and systems engineering. In order to facilitate communi-
cation and sharing of resources, several standards and tools have been de-
veloped [37]. These include standards for representing experimental results
(e.g., MIAME [8], MIAPE [78]), and for representing models (e.g., SBML
[30], CellML [50]). Databases are also a fundamental resource for informa-
tion sharing. Some examples that can be used to build a biological model are
databases with gene annotation (e.g., Entrez Gene [52]), pathway informa-
tion (e.g., KEGG [35]) and enzyme kinetics (e.g., BRENDA [69], SABIO-RK
[65]). Curated models can also be found in publicly available databases (e.g.,
Biomodels.net [43]). Several tools have been developed to construct, analyze
and simulate biological models (e.g., CellDesigner [21], Cytoscape [72], CO-
PASI [28], OptFlux [64]).
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Despite all the resources and tools available, the ultimate goal of Sys-
tems Biology to build a fully detailed cell model is still far from complete.
Although there are initiatives for whole cell simulation, such as the E-cell
project [80, 79], the fact that the models developed are detailed at the bio-
chemical kinetic level, has limited their scope to particular biological pro-
cesses (e.g., mitochondrial metabolism [84], circadian clocks [75]). Recently,
models based on less detailed descriptions that integrate all kinds of biolog-
ical networks, started to appear [12, 44].
Systems Biology has been growing both in academia and industry. The
in silico approach provides a fast and inexpensive way to run experiments
and test new hypothesis. Moreover, although it does not replace labora-
tory experiments completely, it can guide experimental design methods that
save time and resources in the laboratory [16]. Computational models can
be used to understand biological systems through simulations that predict
the cellular behavior, and also to redesign these systems by finding the re-
quired manipulations towards a desired goal. Therefore, they have several
applications both in science and engineering areas.
In biomedical research, computational models are used as a framework
for studying disease mechanisms [29, 60] and for drug discovery [10]. Using
in silico experiments, researchers can find specific drug targets and study the
effect of new drugs at a system-wide level, avoiding potential side-effects.
Industrial biotechnology is another major area of application for Systems
Biology [55]. The creation of microbial factories has a high impact in soci-
ety in terms of economy and sustainability. These applications involve the
redesign of the microbial metabolism for specific production goals. This will
be the main focus of this work and will be explored in more detail in the
next section.
1.2 Metabolic Engineering
The utilization of microbial factories began many centuries ago, even before
microorganisms were discovered. Their first application was the produc-
tion of alcoholic beverages such as wine and beer. Nowadays, biotechnology
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has widespread use in industry for the production of commodity chemicals
and materials [22]. Industrial biotechnology provides cost competitive, en-
vironmental friendly and sustainable alternatives to existing chemical-based
production processes [55].
Among biotechnologicaly produced compounds are pharmaceutical drugs
such as penicillin [59] and insulin [61]. Another major market is the pro-
duction of nutrients such as vitamins [81, 77] and amino acids [31, 47]. The
sustainability and environmental concerns in the recent years have led to a
demand of renewable energy sources as an alternative to petroleum-based
fuels, creating an important market for biofuel production [38, 39].
For biotechnological production to be cost competitive, it is necessary
that the bioconversion of substrates into products has the highest possible
yield. Metabolic engineering is the modification of cellular metabolism for
optimization of a desired production objective [76]. Traditionally, this was
done by directed evolution [3] or random mutagenesis [66]. Although these
approaches have been successful (e.g., over 1000-fold increase in penicillin
production [53]), they do not elucidate the genetic changes that have occurred
in the cells. Consequently, it is not possible to obtain knowledge of the target
changes and to reapply them in further strain improvements.
Metabolic engineering, on the other hand, uses rational strain design
to redirect the metabolic flux towards the desired objective. This can be
achieved by changing the expression of the genes associated with the metabolic
enzymes, such as gene knockout in key metabolic branch points and increased
enzyme expression in the target pathways. Additionally, it is also possi-
ble to add new metabolic functions to an organism by heterologous gene
expression. These manipulations became possible when molecular biology
techniques such as recombinant DNA emerged [23].
In order to guide the rational design of mutant microbial strains it is
necessary to have metabolic models that are able to simulate and predict
the metabolic phenotype of such mutants. The earlier models were based on
mechanistic kinetic descriptions of some of the central metabolic reactions.
Metabolic Control Analysis (MCA) and Biochemical Systems Theory (BST)
are two mathematical frameworks that were developed to analyze the key
4
parameters that control the metabolic flux [13]. However, the difficulty of
obtaining kinetic data for building larger models, together with the recent
development of genome sequencing technologies have decreased the popular-
ity of these models in favor of genome-scale stoichiometric models [14]. In
chapter 3 the connection between these two kind of models is explored in
detail.
Genome sequencing is the first step for creating a genome-scale metabolic
network reconstruction. The advances in DNA sequencing techniques have
greatly decreased the time and cost required for sequencing the complete
genome of an organism [70, 2]. For this reason, the number of sequenced
genomes has been growing exponentially, with hundreds of complete se-
quences currently available [55]. The model reconstruction process begins
with functional annotation of the genome sequences, by comparing against
sequence databases such as GenBank [6] and Entrez Gene [52], followed by
search in metabolic databases such as KEGG [35] and SEED [56] to obtain
the gene-protein-reaction (GPR) associations. This process can be done au-
tomatically and complemented with manual curation using literature data
and organism-specific knowledge [18].
There are currently over 50 genome-scale metabolic reconstructions avail-
able for a variety of organisms [54]. These allow the simulation of the
metabolic phenotype under steady-state conditions, using constraint-based
methods such as the popular Flux Balance Analysis (FBA) [82, 15]. In order
to find the optimal changes for mutant strain design, methods have been
developed that find optimal knockout sets [9, 58] and also target enzymes for
the adjustment of expression levels [62].
1.3 Escherichia coli as a model organism
Perhaps the most fundamental aspect of an industrial biotechnological ap-
plication is the selection of the ideal microorganism to perform as a cellular
factory. Escherichia coli is a bacterium commonly found in the intestinal
flora, and is the most well studied prokaryotic organism. It can be easily
cultivated in the laboratory with inexpensive medium, making it a suitable
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model organism for several applications. In particular, E. coli K-12 is the
most widely used strain in laboratories worldwide and has been a workhorse
for industrial biotechnology [63].
E. coli K-12 was one of the first organisms to be completely sequenced [7],
and it currently has several dedicated projects and resource databases includ-
ing the International E. coli Alliance (IECA) [27], EcoGene [68] and EcoCyc
[36]. Also, some metabolic models of this organism have been published
and are publicly available, including kinetic reconstructions of the central
metabolism [11] and genome-scale stoichiometric reconstructions [17]. For
these reasons, E. coli was selected as the case-study for all the work pre-
sented in this thesis.
There are many successful cases of metabolic engineering applications
that use E. coli strains designed for overproduction of target metabolites
[19]. These include the production of amino acids such as L-valine [57] and
L-threonine [45] as well as other organic compounds for food industry like
vanillin [49], lactic acid [20], succinic acid [46] and lycopene [1]. This microbe
has also had a significant role in the production of different sources of biofuels
[32, 34, 51, 5, 4].
1.4 Motivation for this work
Despite the advances in the area of Systems Biology, and the many successful
cases of metabolic engineering applications, we have not yet reached a point
where we can precisely predict all possible outcomes of the cellular behavior.
The reason is that we have not yet built a fully detailed whole-cell model
for any model organism. In fact, with few exceptions [12, 44], most models
address only each of the main kinds of biological networks (signaling, gene
regulatory and metabolic) individually. Also, given the heterogeneous back-
ground of the Systems Biology community, these models have been based on
a myriad of different formalisms.
Integration of different kinds of biological networks is fundamental for
accurate simulations of cellular behavior. For instance, the simulation of a
gene knockout in a metabolic network is simulated by setting the flux carried
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by the corresponding enzyme to zero. However, this approach disregards all
possible consequent adjustments at the regulatory level. This is of utmost
importance if we consider how cells are robustly designed [48]. Therefore,
this field would benefit from the creation of a modeling framework with a
common modeling formalism, analysis and simulation methods, that sup-
ports all kinds of biological networks. The work presented in this thesis,
addresses the problem of integration of biological network models, with a
focus on improving metabolic network simulation.
1.5 Thesis Outline
Chapter 1 (current chapter) gives a brief introduction to the field of Systems
Biology, its application to metabolic engineering, and the motivation for this
work.
Chapter 2 is a review on modeling formalisms that have been used in Sys-
tems Biology to model all major kinds of biological networks. The formalisms
are compared and analyzed in terms of features provided and successful appli-
cations to different biological networks. The goal is to find the best candidate
suitable for whole-cell modeling. One of the key conclusions is that Petri nets
[26] are a solid candidate for such purpose. Another important observation is
that there is a separation of two distinct approaches for modeling metabolic
networks, which is analyzed in detail in the sequent chapter.
Chapter 3 explores the gap between dynamic and constraint-based models
of metabolism. This is a gap that comes from two opposite model building ap-
proaches. The first is performed in a bottom-up fashion by putting together
kinetic equations for reactions that have been experimentally characterized,
while the second begins with a genome-scale stoichiometric reconstruction
and constrains the metabolic phenotype in a top-down approach by adding
equilibrium, thermodynamic and flux constraints. This gap can also be found
in gene regulatory and signaling networks. Therefore, it is important to ad-
dress this problem if a true integration of different biological networks is
foreseen.
Chapter 4 presents a Petri net based framework for metabolic model
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transformation. Given the limitations of constraint-based models to model
dynamic behavior, there have been recent efforts to generate kinetic models
from stoichiometric reconstructions [73, 74, 33]. Petri nets are a suitable for-
malism to integrate different kinds of biological networks. In this particular
case, discrete and continuous Petri nets can be used to represent, respectively,
stoichiometric and dynamic models. Therefore, we propose this formalism
as an unifying framework for the kinetic inference process. Moreover, the
usually large size of stoichiometric reconstructions results in dynamic models
with a huge number of parameters. To address this problem, we have devel-
oped structural transformation methods for network reduction that can be
used prior to the kinetic inference process, in order to reduce the size of the
generated models.
Chapter 5 explores the influence of enzymatic regulation in the steady-
state flux distribution simulated with dynamic models of metabolism. Cur-
rent approaches for building kinetic metabolic models at the genome-scale
do not account for this kind of regulation. We propose the utilization of ex-
tended Petri Nets as a suitable formalism for modeling metabolic networks
that account for enzymatic regulation, and extend the kinetic inference pro-
cess to this new framework. We compare the metabolic phenotype of mutant
strains simulated with regulated and unregulated models and observe signif-
icant differences in many cases.
Chapter 6 wraps up with general conclusions derived from this work and
elaborates on perspectives for future directions.
1.5.1 Publications derived from this work
During the development of this work, several publications were written.
Chapters 2–5 are based on those publications, adapted with minor changes to
the format of this thesis. The three supervisors of the thesis are co-authors of
all publications and revised the final manuscripts. Rafael Costa contributed
with ideas and discussion, mainly in the topics of dynamic modeling and
parameter estimation, and is also co-author of all publications.
Chapter 2 is based on the review article “Modeling formalisms in Systems
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Biology” (submitted), which is a extended version of the article “A critical re-
view on modelling formalisms and simulation tools in Computational Biosys-
tems” published in Distributed Computing, Artificial Intelligence, Bioinfor-
matics, Soft Computing, and Ambient Assisted Living, volume 5518, pages
1063–1070, 2009. Miguel Rocha helped reviewing the computational for-
malisms and is co-author of this publication.
Chapter 3 is based on the article “Exploring the gap between dynamic and
constraint-based models of metabolism” (in preparation).
Chapter 4 is based on the article “Model transformation of metabolic
networks using a Petri net based framework” published at the International
Workshop on Biological Processes & Petri Nets (BioPPN 2010), Braga, Por-
tugal, 2010.
Chapter 5 is based on the article “Accounting for enzymatic regulation in
large-scale kinetic reconstructions of metabolism” (in preparation).
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Chapter 2
Modeling Formalisms
This chapter is based on the review article “Modeling formalisms in Systems
Biology” (submitted), which is a extended version of the article “A critical re-
view on modelling formalisms and simulation tools in Computational Biosys-
tems” published in Distributed Computing, Artificial Intelligence, Bioinfor-
matics, Soft Computing, and Ambient Assisted Living, volume 5518, pages
1063–1070, 2009.
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Abstract
The field of Systems Biology has taken advantage of computational tools and
high-throughput experimental data to model several biological processes in-
cluding signaling, gene regulatory, and metabolic networks. However, most
of these models are specific to each kind of network. The interconnection
between all biological processes demands a whole-cell modeling framework
for a complete understanding of cellular systems. Here, we describe the
main types of cellular processes and the features required by an integrated
framework for modeling, analyzing and simulating such processes. We then
review several modeling formalisms that have been used in Systems Biology
including Boolean networks, Bayesian networks, Petri nets, process algebras,
constraint-based models, differential equations, rule-based models, interact-
ing state machines, cellular automata, and agent-based models. We compare
the features provided by different formalisms, and discuss recent approaches
in the conversion and integration of these formalisms. Considering that no
formalism fits all demands, it may become common to use different for-
malisms for different stages of the modeling process. Support for different
extensions, hierarchical structure, multi-scale and robust model inference are
key features for a framework that will support increasingly complex models.
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2.1 Introduction
Living organisms are complex systems that emerge from the fundamental
building blocks of life. Systems Biology (SB) is a field of science that stud-
ies these complex phenomena currently, mainly at the cellular level [102].
Understanding the mechanisms of the cell is essential for research in sev-
eral areas such as drug development and biotechnological production. In the
latter case, metabolic engineering approaches are applied in the creation of
microbial strains with increased productivity of compounds with industrial
interest such as biofuels and pharmaceutical products [170]. Using mathe-
matical models of cellular metabolism, it is possible to systematically test and
predict manipulations, such as gene knockouts, that generate (sub)optimal
phenotypes for specific applications [18, 129]. These models are typically
built in an iterative cycle of experiment and refinement, by multidisciplinary
research teams that include biologists, engineers and computer scientists.
The interconnection between different cellular processes, such as metab-
olism and genetic regulation, reflects the importance of the holistic approach
introduced by the SB paradigm in replacement of traditional reductionist
methods. Although most cellular components have been studied individu-
ally, the behavior of the cell emerges at the network-level and requires an
integrative analysis.
Recent high-throughput experimental methods allow to generate the so-
called omics data (e.g.: genomics, transcriptomics, proteomics, metabolomics,
fluxomics) that have allowed the reconstruction of many biological networks
[57]. However, despite the great advances in the area, we are still far from a
whole-cell computational model that integrates and simulates all the compo-
nents of a living cell. Due to the enormous size and complexity of intracel-
lular biological networks, computational cell models tend to be partial and
focused on the application of interest. Also, due to the multidisciplinarity
of the field, these models are based on several different kinds of formalisms,
including those based on graphs (e.g. Boolean networks) and equation-based
ones (e.g. ordinary differential equations). This diversity can lead to the frag-
mentation of modeling efforts as it hampers the integration of models from
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different sources. Therefore, the whole-cell simulation goals of SB would
benefit with the development of a framework for modeling, analysis and sim-
ulation that is based on a single formalism. This formalism should be able to
integrate the entities and their relationships, spanning all kinds of biological
networks.
This work reviews several modeling formalisms that have been used in
SB, comparing their features and relevant applications. We opted to focus
on the formalisms rather than the tools as they are the essence of the mod-
eling approach. For the software tools implementing the formalisms, the
interested reader may use the respective references. This review is divided
into three parts. Section 2.2 describes the main types of biological networks
that the models try to represent. Section 2.3 describes the relevant features
for modeling these networks and section 2.4 explores the modeling formalisms
found in the literature. Section 2.5 compares the formalisms and discusses
their potential from an integrative perspective. Section 2.6 presents some
conclusions and future directions regarding the most suitable formalisms for
an integrated whole-cell framework.
2.2 Biological Networks
Cells are composed by thousands of components that interact in a myriad of
ways. Despite this intricate interconnection, it is usual to divide and classify
these networks according to their biological function (Fig. 2.1). The main
types of networks are signaling, gene regulatory and metabolic (although
some authors also classify protein-protein interactions as another type of
network). These main types of networks will be briefly described.
2.2.1 Signaling networks
Signal transduction is a process for cellular communication where the cell
receives (and responds to) external stimuli from other cells and from the
environment. It affects most of the basic cell control mechanisms such as dif-
ferentiation and apoptosis. The transduction process begins with the binding
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Figure 2.1: Conceptual representation of the main cellular processes. Signal-
ing cascades receive external signals from the environment. Gene regulatory
networks control the transcription level of genes. Metabolic networks obtain
energy and carbon from external sources using internal conversion steps.
(Figure created with the free software tool CellDesigner [64] that uses the
graphical notations defined in [103].)
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of an extracellular signaling molecule to a cell-surface receptor. The signal
is then propagated and amplified inside the cell through signaling cascades
that involve a series of trigger reactions such as protein phosphorylation. The
output of these cascades is connected to gene regulation in order to control
cell function. Signal transduction pathways are able to crosstalk, forming
complex signaling networks [71, 3].
2.2.2 Gene regulatory networks
Gene regulation controls the expression of genes and, consequently, all cellu-
lar functions. Although all of the cell functionality is encoded in the genome
by thousands of genes, it is essential for the survival of the cell that differ-
ent functions are active in different stages of life and in the adaptation to
different environments.
Gene expression is a process that involves transcription of the gene into
mRNA, followed by translation to a protein, which may also be subject to
post-translational modifications. The transcription process is controlled by
transcription factors that can be activators or inhibitors. Transcription fac-
tors are themselves encoded by genes and subject to regulation, which alto-
gether forms complex regulatory networks [156, 95].
2.2.3 Metabolic networks
Metabolism is a mechanism composed by a set of biochemical reactions, by
which the cell sustains its growth and energy requirements. It includes several
catabolic and anabolic pathways of enzyme–catalyzed reactions that import
substrates from the environment and transform them into energy and build-
ing blocks required to build the cellular components. Metabolic pathways are
interconnected through intermediate metabolites, forming complex networks.
Gene regulation controls the production of enzymes and, consequently, di-
rects the metabolic flux through the appropriate pathways in function of
substrate availability and nutritional requirements [171, 127].
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2.3 Modeling Requirements
Due to the different properties and behavior of the biological networks, they
usually require different modeling features (although some desired features
such as graphical visualization are common to all). For instance, features
such as stochasticity and multi-state components may be important for sig-
naling but not for metabolic networks. A summary of the major modeling
features required by these networks is presented next.
2.3.1 Network visualization
SB is a multidisciplinary research field gathering biologists, computer sci-
entists and engineers. Therefore, biological models should be expressed as
intuitively as possible and easily interpreted by people from different areas.
For that matter, graph and diagram based formalisms can be more appealing
than mathematical or textual notations. Such formalisms can take advan-
tage of state of the art network visualization tools, that when compared to
traditional textbook diagrams, allow a much better understanding of the
interconnections in large-scale networks, as well as the integration of hetero-
geneous data sources [131].
2.3.2 Topological analysis
A considerable amount of the work in this field is based on topological anal-
ysis of biological networks. In this case, graph-based representations also
play a fundamental role. The analysis of the topological properties of these
graphs, such as degree distribution, clustering coefficient, shortest paths or
network motifs can reveal information from biological networks, including
organization, robustness and redundancy [90, 10, 8].
2.3.3 Modularity and hierarchy
Despite its great complexity, the cell is organized as a set of connected mod-
ules with specific functions [79, 143]. Taking advantage of this modularity
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can help to alleviate the complexity burden, facilitating its analysis. Com-
positionality is a related concept meaning that two modeling blocks can be
aggregated together into one model without changes to any of the submodels.
This property can be of special interest for applications in Synthetic Biology
[7].
While modularity represents the horizontal organization of the cell, liv-
ing systems also present vertical organization [30]. Molecules, cells, tissues,
organs, organisms, populations and ecosystems reflect the hierarchical or-
ganization of life. A modeling formalism that supports hierarchical models
and different levels of abstraction will cope with models that connect vertical
organization layers. Also, it will have the required flexibility to cope with
the different modeling approaches in SB, namely, top-down, bottom-up and
middle-out [125].
2.3.4 Multi-state components
Some compounds may have multiple states, for example, a protein may be
modified by phosphorylation. This is a very common case in signaling net-
works. The state of a protein can affect its functionality and consequently
the reactions in which it participates. Therefore, different states are rep-
resented by different entities. However, a protein with n binding sites will
have 2n possible states, which results in a combinatorial explosion of entities
and reactions [81, 15]. To avoid this problem, a suitable modeling formalism
should consider entities with internal states and state-dependent reactions.
2.3.5 Spatial structure and compartmentalization
On its lowest level, the cell can be seen as a bag of mixed molecules. How-
ever, this bag is compartmentalized and requires transport processes for some
species to travel between compartments. Furthermore, in some compart-
ments, including the cytosol, the high viscosity, slow diffusion and amount
of molecules may not be sufficient to guarantee a spatial homogeneity [172].
Spatial localization and concentration gradients are actually important mech-
anisms in biological processes such as morphogenesis [175].
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2.3.6 Qualitative analysis
Experimental determination of kinetic parameters to build quantitative mod-
els is a cumbersome task. Furthermore, they are dependent on the exper-
imental conditions, and there is generally no guarantee that the in vitro
values will match the in vivo conditions [173]. Therefore, several models are
only qualitative. Although these models do not allow for quantitative simu-
lations, they allow us to ask qualitative questions about the system and to
learn valuable knowledge. For instance, elementary mode analysis is used for
calculating all possible pathways through a metabolic network [157].
2.3.7 Dynamic simulation
Dynamic simulation allows the prediction of the transient behavior of a sys-
tem under different conditions. The simulation approach depends on the
type of components included in the model, which depend not only on the
nature of the involved interactions but also on the available information for
their characterization. In regulatory networks, genes are activated and de-
activated through the transcription machinery. Due to its complexity and
the lack of kinetic information, the details of the machinery are usually not
considered. Instead, genes are modeled by discrete (typically boolean) vari-
ables that change synchronously through discrete time steps. Synchronized
simulation is the simplest simulation method and requires models with little
detail.
In biological processes like signaling cascades, that are triggered by a
low number of signaling molecules, it is important to take into considera-
tion the inherent stochasticity in the diffusion of these molecules. Stochastic
simulation is a common approach for simulation of signaling networks [36].
This approach requires the attribution of probability functions for each re-
action in the model. Metabolic reactions, on the other hand, comprise large
quantities of metabolites. Therefore, their behavior can be averaged and
modeled by continuous variables governed by deterministic rate laws [27]. In
both cases, experimental data is required to estimate the parameters in the
models, which is a significant bottleneck in the modeling process.
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2.3.8 Standardization
Biological models need to be represented in a common format for exchange
between different tools. The Systems Biology Markup Language (SBML)
has become the de facto standard of the SB community, and is currently
supported by over two hundred tools [84]. It is an XML–based language for
representation of species, compartments, reactions and their specific prop-
erties such as concentrations, volumes, stoichiometry and rate laws. It also
facilitates the storage of tool specific data using appropriate tags. SBML
was initially focused on biochemical reaction networks such as metabolic and
signaling pathways, therefore it is not so well-suited for modeling other kinds
of processes such as regulatory networks which are better described by logical
models. Nevertheless, these and other limitations are being addressed in the
development of future releases [59, 83].
CellML is another XML–based language with a similar purpose to SBML
albeit more generic [117]. The Systems Biology Graphical Notation (SBGN)
[111] is a standard that focuses on the graphical notation and may be seen
as a complement to SBML. It addresses the visualization concerns discussed
previously, specially the creation of graphical models with a common notation
that can be shared and unambiguously interpreted by people from different
areas.
2.4 Modeling Formalisms
Many formalisms have been used to approach the modeling of biological sys-
tems, in part due to the diversity of phenomena that occur in living systems,
and also due to the multidisciplinarity of the research teams. Biologists may
be more familiar with mathematical modeling and computer scientists may be
religious to their computational formalism of choice. The dichotomy between
mathematical and computational models has been discussed elsewhere [85].
Although they follow different approaches (denotational vs operational), it
has been questioned if there is such a clear separation between mathemat-
ical and computational models. Therefore, in the following we will briefly
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Table 2.1: Overview of some of the literature references on the applica-
tions of each formalism, classified by the type of process. (BN) Boolean
networks; (Bay) Bayesian networks; (PN) Petri nets; (PA) Process algebras;
(CB) Constraint-based models; (DE) Differential equations; (RB) Rule-based
models; (ISM) Interacting state machines; (CA) Cellular automata; (AB)
Agent-based models.
Signaling Gene regulatory Metabolic
BN [76, 153] [2, 47, 97, 114, 164]
Bay [150, 151] [50, 86, 100, 134, 195]
PN [17, 28, 77, 152] [25, 26] [106, 110, 144, 165, 192]
PA [141, 146, 147, 148]
CB [112, 128] [67, 112] [56, 155, 157, 160, 162]
DE [177] [14, 29, 45, 177] [27, 88, 149]
RB [11, 12, 13, 16]
ISM [52, 61, 62, 94]
CA [98, 189] [185] [183, 185]
AB [6, 72, 137, 138] [105]
describe several formalisms regardless of such distinction.
There are other reviews on modeling formalisms in the literature [60, 120],
some focusing on particular processes, such as gene regulatory networks
[156, 95] or signaling pathways [4]. However, to the best of our knowledge,
none covers the whole spectrum presented in this work. Note that besides
the intracellular level, several studies in SB also address the cellular pop-
ulation level. Therefore, formalisms for modeling the dynamics of cellular
populations have also received attention in the field and will be considered in
this work. Table 2.1 summarizes some of the literature references reviewed
herein, classified by type of intracellular process implemented. Toy examples
of the formalisms with graphical notation are depicted in Figure 2.2.
2.4.1 Boolean networks
Boolean networks (Fig. 2.2a) were introduced by Kauffman in 1969 to model
gene regulatory networks [97]. They consist on networks of genes, modeled
by boolean variables that represent active and inactive states. At each time
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Figure 2.2: Toy examples of the formalisms with visual representation. a)
Boolean network: node (gene) a is deactivated by node c, node b is activated
by node a, node d is activated by node a and deactivated by node b; b)
Bayesian network: the value of each node (gene) c, d, and e, is given by a
probability function that is conditionally dependent on the values of nodes
a and b; c) Petri net: transition (reaction) p consumes one token (molecule)
from place (substance) a and produces one token in place c, transition q
consumes tokens from places a and b and produces one token in place c; d)
Agent-based model: two types of agents (light gray and dark gray), repre-
senting two different kinds of cell (or two kinds of molecules) move freely and
interact within the containing space; e) Interacting state machine: a system
that can move from state a to state c, where state a as an internal sub-state
b and state c has two internal sub-states, d and e; f) Contact map of a
rule-based model: agents (proteins) P, Q, R and S, contain several binding
sites (a to f ), edges between binding sites describe possible interactions (e.g.
phosphorylation); g) Cellular automata: a 10 × 10 grid with three possible
values (empty, light gray or dark gray), representing two different kinds of
cells (or two kinds of molecules) that can change by interacting with their
surrounding neighbors.
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step, the state of each gene is determined by a logic rule which is a function
of the state of its regulators. The state of all genes forms a global state
that changes synchronously. For large network sizes (n nodes) it becomes
impractical to explore all possible states (2n). This type of model can be used
to find steady-states (called attractors), and to analyze network robustness
[114]. Boolean networks can be inferred directly from experimental gene
expression time-series data [1, 47]. They have also been applied in some
studies to model signaling pathways [76, 153]. To cope with the inherent
noise and the uncertainty in biological processes, stochastic extensions like
Boolean networks with noise [2] and Probabilistic Boolean networks [164]
were introduced.
2.4.2 Bayesian networks
Bayesian networks (Fig. 2.2b) were introduced in the 80’s by the work of
Pearl [132]. They are a special type of probabilistic graphs. Their nodes
represent random variables (discrete or continuous) and the edges represent
conditional dependencies, forming a directed acyclic graph. Each node con-
tains a probabilistic function that is dependent on the values of its input
nodes. There are learning methods to infer both structure and probability
parameters with support for incomplete data. This flexibility makes Bayesian
networks specially interesting for biological applications. They have been
used for inferring and representing gene regulatory [63, 134, 75, 9] and sig-
naling networks [150, 151]. One disadvantage of Bayesian networks is the
inability to model feedback loops, which is a common motif in biological
networks. This limitation can be overcome by dynamic Bayesian networks
[86, 100, 195, 50]. In this case, the variables are replicated for each time step
and the feedback is modeled by connecting the nodes at adjacent time steps.
2.4.3 Petri nets
Petri nets (Fig. 2.2c) were created in the 60’s by Carl Adam Petri for the
modeling and analysis of concurrent systems [136]. They are bipartite graphs
with two types of nodes, places and transitions, connected by directed arcs.
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Places hold tokens that can be produced (respectively, consumed) when an
input (respectively, output) transition fires. The execution of a Petri net is
non-deterministic and specially suited for distributed systems with concur-
rent events. Their application to biological processes began in 1983, by the
work of Reddy and coworkers, to overcome the limitations in quantitative
analysis of metabolic pathways [144].
There are currently several Petri net extensions (e.g.: coloured, timed,
stochastic, continuous, hybrid, hierarchical, functional), forming a very ver-
satile framework for both qualitative and quantitative analysis. Due to this
versatility, they have been used in metabolic [110, 192, 106], gene regulatory
[25, 26], and signaling networks [152, 28, 17, 77]. Also, they are suited for in-
tegrating different types of networks, such as gene regulatory and metabolic
[165].
2.4.4 Process algebras
Process algebras are a family of formal languages for modeling concurrent
systems. They generally consist on a set of process primitives, operators for
sequential and parallel composition of processes, and communication chan-
nels. The Calculus of Communicating Systems (CCS) was one of the first
process algebras, developed during the 70’s by Robin Milner [122], and later
gave origin to the more popular pi-calculus [123]. In SB the application
of process algebras has been mainly focused on signaling pathways due to
their similarity to communication processes. About a decade ago, Regev and
coworkers published their pioneer work on the representation of signaling
pathways with pi-calculus [147, 148]. They later extended their work using
stochastic pi-calculus (BioSpi) to support quantitative simulations [141] and
using Ambient calculus (BioAmbients) for representation of compartments
[146]. Other relevant biological applications of process algebras include Bio-
calculus [124], κ-calculus (for protein-protein interactions) [44], CCS-R [43],
Beta binders [140], Brane Calculi [22], SpacePi [91], Bio-PEPA [31, 32] and
BlenX [46, 139].
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2.4.5 Constraint-based models
Constraint-based models for cellular metabolism began spreading during the
90’s, mainly influenced by the work of Palsson and coworkers [178]. Assuming
that cells rapidly reach a steady-state, these models overcome the limitations
in lack of experimental data for parameter estimation inherent in fully de-
tailed dynamic models. They are based on stoichiometric, thermodynamic
and enzyme capacity constraints [145, 142]. Instead of a single solution,
they define a space of possible solutions representing different phenotypes
that comply with the constraints. The simplicity in this formulation allows
its application to genome-scale metabolic models comprising thousands of
reactions, such as the most recent metabolic reconstruction of E. coli [56].
Constraint-based models have been used in metabolic engineering strate-
gies for the determination of flux distributions (metabolic flux analysis [184],
flux balance analysis [96]), knockout phenotype predictions (minimization of
metabolic adjustment [160], regulatory on/off minimization [162]) or enumer-
ating all possible pathways (extreme pathways [155], elementary flux modes
[157]). Although their main application has been on metabolic networks,
there are recent efforts towards application on gene regulatory and signaling
networks [128, 67, 112].
2.4.6 Differential equations
Differential equations describe the rate of change of continuous variables.
They are typically used for modeling dynamical systems in several areas.
Systems of non-linear ordinary differential equations (ODEs) have been used
in SB to describe the variation of the amount of species in the modeled sys-
tem as a function of time. They have been applied to all kinds of biological
pathways [27, 149, 29, 177]. With a fully detailed kinetic model, one can
perform time-course simulations, predict the response to different inputs and
design system controllers. However, building ODE models requires insight
into the reaction mechanisms to select the appropriate rate laws, and experi-
mental data to estimate the kinetic parameters. The lack of kinetic data has
limited the size of the modeled networks to pathway size, with exception for
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the human red blood cell model [88].
Approximative rate laws such as generalized mass action (GMA) [82],
S-systems [154], lin-log [179], and convenience kinetics [116], have compact
standard formulations that can facilitate the development and analysis of
large-scale models [80, 37]. This opens the possibility for kinetic modeling at
the genome-scale [167].
Other types of differential equations, such as stochastic differential equa-
tions (SDEs) and partial differential equations (PDEs) can be used respec-
tively to account for stochastic effects and spatial distribution [176]. Piecewise-
linear differential equations (PLDEs) have been used to integrate discrete and
continuous features in gene regulatory networks [45, 14].
2.4.7 Rule-based models
Rule-based (Fig. 2.2f) modeling comprises a recent approach to the problem
of multi-state components in biological models. In rule-based formalisms the
species are defined in a structured manner and support multiple states. The
reaction rules are defined as transformations of classes of species, avoiding
the need for specifying one reaction per each possible state of a species. This
high-level specification is then automatically transformed into a biochemical
network with the set of species and reactions generated by the specification.
This kind of formalism is implemented in BioNetGen [15] which generates
an ODE model or a stochastic simulation from the ruled-based specifica-
tion. It has been applied in the modeling of different signaling pathways
[16, 11, 12, 13]. A similar rule-based formalism used for this kind of path-
ways is the κ language, where the species are defined by agents that have
a structured interface for interaction with other agents [41, 42, 58]. The
possible interactions are defined by a set of rules, which can be visualized
by a contact map. BIOCHAM implements a rule-based approach for model
specification which is complemented with a temporal logic language for the
verification of the properties the biological models [20].
The main advantage of the rule-based approach is that it can avoid the
combinatorial explosion problem in the generation and simulation of the com-
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plete reaction network by performing stochastic simulations that only instan-
tiate the species and reactions as they become available [33, 34] or by the
generation of coarse-grained ODE systems [58]. Spatial simulation has been
addressed recently by the inclusion of geometric information as part of the
structure of the species [74].
2.4.8 Interacting state machines
Interacting state (Fig. 2.2e) machines are diagram-based formalisms that
describe the temporal behavior of a system based on the changes in the states
of its parts. They are suited to model biological behavior in a qualitative way
as they require little quantitative data. They differ from other approaches as
they define a system in terms of its states rather than its components. They
are typically used for model checking and interactive execution.
One such formalism is Statecharts, developed by David Harel during the
80’s [78] that was first applied in biology for modeling the T-cell activation
process [94, 52] and more recently in pancreatic organogenesis [161]. In this
formalism, the state of a system may contain sub-states at multiple levels,
allowing an hierarchical view of the system and the relation between events
at smaller and larger scales. Other related formalisms are Reactive Modules
[5] and Live Sequence Charts [40], which, along with the former, have been
applied in the modelling of C. elegans vulval development [62, 61].
2.4.9 Cellular automata
Cellular automata (Fig. 2.2g) were created by von Neumann and Ulam in
the 40’s [181]. They are discrete dynamic models that consist on a grid
of cells with a finite number of states. A cellular automaton has an initial
configuration that changes at each time step through a predefined rule that
calculates the state of each cell as a function of the state of its neighbors at the
previous step. They are specially suited for modeling complex phenomena
in a scale-free manner and have been used in biological studies for a long
time [55]. Due to their spatial features their main applications are related to
molecular dynamics and cellular population dynamics.
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Application examples at the molecular level include enzyme reaction net-
works that account for spatial diffusion [183] and signaling pathways [189, 98].
At the cellular level they were used for models such as those of bacterial ag-
gregation [168] and HIV infection [194, 35]. Dynamic cellular automata are
a variation of cellular automata that allows for movement of the cell con-
tents inside the grid, mimicking brownian motion. They were used to model
enzyme kinetics, molecular diffusion and genetic circuits [185].
2.4.10 Agent-based models
Agent-based models (Fig. 2.2d) describe the interactions among multiple
autonomous agents. They are similar in concept to cellular automata, except
in this case, instead of using a grid and synchronized time steps, the agents
move freely within the containing space. Likewise, they are used to study
complex phenomena and emergent dynamics using populations of agents with
simple rules. At the molecular level they have been mainly used to build
models of signaling pathways that account for spatial distribution and the
structural properties of the cell [72, 138, 137, 6]. Recently, they have also
been applied to metabolic reactions [105]. However, their main application
is at the multi-cellular level, where they have been used to study granuloma
formation [159], tumor growth [193, 54], morphogenesis [73], chemotaxis [53],
immune responses [118, 115], and several others [174, 121].
2.4.11 Other
There are other modeling formalisms that have been used in SB which are
worth mentioning. Cybernetic modeling is one of the earliest approaches
for dynamic modeling that was used in bioprocess applications [109, 48]. A
recent approach combines cybernetic variables with elementary flux modes
[191, 99]. Hybrid automata addressed the integration of discrete and contin-
uous components in the Delta-Notch signaling pathway [65, 66]. Artificial
neural networks were used to model gene expression [180]. Molecular inter-
action maps are a popular graph-based formalism created by Kohn in 1999
[107, 108, 119] that influenced the SBGN standard [111]. Other graph-based
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formalisms include modular interaction networks [190] and logical interaction
hypergraphs [104]. The P systems formalism created by Paun in 1998, in-
spired the area of membrane computing [130] and has been recently applied
in SB [135, 21]. Chemical organization theory is a recent approach for mod-
eling biochemical reaction networks that uses set theory to analyze how they
can be decomposed into self-maintaining subnetworks called organizations,
that reveal dynamic properties of the system [49]. It has been used to ana-
lyze different types of networks including signaling pathways and regulated
metabolic networks [23, 24, 92, 93].
2.5 Discussion
The diversity of problems studied in SB gave rise to the application of sev-
eral different types of formalisms. Some of the literature references for each
formalism, classified by the type of biological process described, are shown in
Table 2.1. We can observe that only four formalisms (Petri nets, constraint-
based models, differential equations and cellular automata) have been ap-
plied to all three types of biological networks, which makes them potential
candidates as a suitable integrative formalism for whole-cell modeling. Nev-
ertheless, this does not automatically exclude other formalisms from this
possibility as well. Another interesting observation is that metabolism is the
biological process with the smaller number of formalisms applied. This is
likely due to the fact that its two main frameworks (differential equations
and constraint-based) are well suited for modeling metabolic networks. On
the other hand, all of the formalisms have been applied to signaling pathways.
One possible reason for this, is the fact that they have a larger number of
modeling feature requirements, including spatial localization and multi-state
components.
The modeling features provided by the formalisms reviewed in this work
are compared in Table 2.2. Some of the features are only available in ex-
tensions of the formalisms. We can observe that no single formalism covers
the whole spectrum of features desired for modeling all kinds of biological
components. Petri nets and rule-based models are among the formalisms
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Table 2.2: Modeling formalisms and implemented features. (BN) Boolean
networks; (Bay) Bayesian networks; (PN) Petri nets; (PA) Process algebras;
(CB) Constraint-based models; (DE) Differential equations; (RB) Rule-based
models; (ISM) Interacting state machines; (CA) Cellular automata; (AB)
Agent-based models; (+) Supported feature; (e) Available through extension.
BN Bay PN PA CB DE RB ISM CA AB
Visualization + + + + + + +
Topology + + + +
Modularity + + + +
Hierarchy e e +
Multi-state e + + + +
Compartments e + + +
Spatial e e + +
Qualitative + + + + + +
Synchronized + e +
Stochastic e + e + e + + + +
Continuous e + +
that cover most features. Petri nets have several extensions available, and
although none of the extensions alone fulfills all requisites, altogether they
form a very versatile modeling framework. Rule-based models present a high
level of abstraction and can be used for stochastic simulation and automatic
generation of lower level ODE-based representations. Therefore, they take
advantage of the analytic power of abstract representations, preserving the
ability to generate stochastic and deterministic simulations.
Although none of the formalisms implements all the required features,
this is not necessarily a limitation, since different formalisms can be used
at different stages of the modeling process. The model construction pro-
cess begins with biochemical knowledge and experimental data that allow an
enumeration of the components and connections in the system. Graph-based
models, such as Boolean networks, Bayesian networks and Petri nets can
be used for modeling this map of interactions. This allows a deeper under-
standing of the organization of the system through topological analysis, and
drives new experiments by finding gaps in the models. This kind of models
also allows qualitative descriptions of system behavior and coarse simulation
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capabilities. If the reactions’ stoichiometry and directionality are known, one
may analyze the steady-states of the system using constraint-based models.
Finally, if extensive experimental data is available to infer the kinetics of
the reactions, probabilistic or deterministic rate laws can be used to create
dynamic models. These are used to generate time-course simulations under
different sets of initial conditions. Stochastic process algebras, stochastic
Petri nets, continuous Petri nets, rule-based models and differential equa-
tions, would all be ideal candidates for this purpose.
Cellular automata and agent-based models account for the individual
replicas of each component in the system. When applied at the molecular
level, this paradigm provides accurate simulations of small sets of biochemical
reactions that account for spatial diffusion. However, it becomes infeasible
to perform simulations at the genome-scale network level, as this would im-
ply modeling every copy of all substances present in the cell. Nevertheless,
this approach is very convenient for modeling at the cell population level,
as it allows to track changes in individual cells and to study the emergent
properties of cellular communities.
The inability of the formalisms to fit all purposes has driven the develop-
ment of methodologies to convert between different formalisms. Two differ-
ent methods have been proposed to convert Boolean networks to Petri nets
[25, 169]. Boolean networks have also been converted to constraint-based
models [68] and to ODEs [186]. Other formalisms have also been converted
to ODEs, including constraint-based models [166], Petri nets [69], process
algebras [19] and rule-based models [58]. When the mappings are made from
abstract to more detailed models they usually require some assumptions and
insight into the reaction mechanisms. The language for biochemical systems
(LBS) is a recent language that integrates a rule-based approach with pro-
cess calculus, and supports the generation of Petri nets, ODEs and continuous
time Markov chains [133].
Along with the conversion between formalisms, there is also a recent trend
for developing methods that support integrated simulation of different for-
malisms in order to integrate different kinds of biological networks, where
each network is modeled in its own formalism. Extensions of flux balance
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analysis (FBA) [96], such as regulated FBA (rFBA) [38] and steady-state reg-
ulated FBA (SR-FBA) [163] incorporate boolean rules into constraint-based
models for integrated simulation of regulatory and metabolic networks. In-
tegrated FBA (iFBA) extends rFBA by integrating kinetic information from
ODE models [39]. Integrated dynamic FBA (idFBA) aims to integrate sig-
naling, regulatory and metabolic networks by modeling all networks in the
constraint-based formulation [113]. Biochemical systems theory (BST) has
been recently integrated with Hybrid Functional Petri Nets (HFPN) in order
to integrate metabolic, regulatory and signaling networks, in a framework
that accounts for different time-scales as well as discrete, stochastic and con-
tinuous effects [187, 188].
In search for a proper formalism perhaps the most important aspect to
consider is the balance between simplicity and expressiveness. There is a price
to pay for the amount of features provided by a formalism, which may come at
the cost of increased model complexity. The complexity of the representation
and the number of parameters determines the amount of experimental data
required for model construction. This is the reason why the most simple
formalisms such as Boolean networks and constraint-based models have been
used to build, respectively, gene regulatory and metabolic networks at the
genome scale. This concern is most critical when not only the parameters
but also the network structure are unknown. Model inference (also known
as reverse engineering) methods are applied in these cases. They have been
used to infer Boolean networks [1, 47], Bayesian networks [63, 9], Petri nets
[126, 51] and ODEs [101, 87] from experimental data. However, the scalability
of these methods is greatly dependent on the simplicity of the underlying
formalism.
2.6 Conclusions
With the myriad of formalisms that have been applied in SB, we face the
challenge of choosing the proper formalism for the problem in hands. As more
data become available for network reconstruction, we move towards integra-
tion of all kinds of biological networks, namely signaling, gene regulatory
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and metabolic. Although some formalisms like Petri nets, constraint-based
models and differential equations have been applied for all these networks, no
single formalism covers the whole spectrum of functionalities available in the
different formalisms reviewed in this work. Petri nets have several extensions
available, covering most of the features analyzed (Table 2.2). However, they
lack support for compartments and spatial localization. Rule-based models
are another strong candidate as they also cover a great part of the modeling
features. In general, formalisms with a visual format can be more appealing
and reveal insight into the system functioning before simulation is possible.
This is particularly important given the lack of kinetic data for larger models.
A common problem in the analysis of biological networks is the combi-
natorial explosion that originates from the complexity of large models. A
typical example is the computation of elementary flux modes, which is cur-
rently still infeasible at the genome-scale, requiring modular decomposition
of the networks [158]. This problem will aggravate as we get closer to whole-
cell modeling. The solution may reside in the application of hierarchical
formalisms to represent an intermediate level between the reaction and the
cell. As stated elsewhere, one should not “model bulldozers with quarks”
[70]. Hierarchical Petri nets, BioAmbients and Statecharts are formalisms
that support hierarchical modeling.
Models of cell populations are also becoming more frequent. They are
used to study scenarios like cell differentiation, chemotaxis, infections or
tumor growth. This kind of models depends on the internal dynamics of the
cells as well as population dynamics. Therefore, they require modeling of
interactions across organizational scales [182]. It is possible that these multi-
scale models will require the integration of different formalisms. For instance,
the evolution of a population of cells could be modeled by an agent-based
model, with each agent having a boolean network for internal representation
of its gene expression.
In order to convert between different formalisms it is important to have
a standard representation format that preserves most of the features in the
models. SBML is the most popular standard in the SB community, currently
supported by over two hundred tools [84]. Most of the modeling features cov-
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ered herein have been proposed for future versions of SBML [59]. These in-
clude hierarchical model composition, rule-based modeling, spatial geometry
and alternative mathematical representations.
Given the size and complexity of the biological networks operating inside
the cell, the model building process is based on iterative steps of refine-
ment and validation. Recent approaches for genome-scale kinetic modeling
of metabolism, begin with the network topology, modeled in the constraint-
based framework, and then refine the models by adding the kinetic structure
in order to generate ODE models [89, 167]. Petri nets seem to be a promis-
ing formalism for this purpose, given that discrete Petri nets can model the
network topology, and can then be used as a scaffold for the generation of dy-
namic models based on continuous or stochastic Petri nets. The fact that the
same kind of formalism is used during the whole model refinement process,
helps the creation of more straightforward and formal methods for automatic
mapping and validation of the models.
Many of the proposed formalisms, such as Petri nets or process algebras,
were originally created by the computational community for the specification
of software systems, where the final system has to comply to the model. The
biological community faces the opposite problem, where the model has to
mimic the system’s behavior, and where most components cannot even be
measured directly. Therefore, a proper framework for SB must provide not
only a suitable formalism with attractive features and simulation methods,
but also methods for model inference and parameter estimation that are
sufficiently robust to handle experimental data that are incomplete and prone
to measurement error.
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Chapter 3
Dynamic vs Constraint-based
modeling
This chapter is based on the article “Exploring the gap between dynamic and
constraint-based models of metabolism” (in preparation).
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Abstract
Systems biology provides new approaches for metabolic engineering through
the development of models and methods for simulation and optimization of
microbial metabolism. Currently, there are two different modeling frame-
works in common use, dynamic and constraint-based models. The construc-
tion of dynamic models with detailed kinetic rate laws has been limited to
central pathways due to the large volume of experimental data required for
parameter estimation. On the other hand, constraint-based models that de-
fine a space of solutions for the steady-state flux distribution, have been used
for genome-scale stoichiometric reconstruction. In this work, we explore the
relationship between these two types of model by comparing and analyzing
the dynamic and constraint-based formulations of the same model of the
central carbon metabolism of E. coli. Our results show that, if the kinetic
parameters of the dynamic model are unconstrained, the space of steady
states described by both types of model is the same. However, the impo-
sition of parameter ranges can be mapped into kinetically feasible regions
of the solution space. Therefore, if at least some of the kinetic parameters
are known, dynamic models can be used to generate constraints that reduce
the solution space of constraint-based models, eliminating infeasible solutions
and increasing the accuracy of simulation and optimization methods.
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3.1 Introduction
The prevalence of systems approaches to biological problems has renewed
interest in mathematical models as fundamental research tools for performing
in silico experiments of biological systems [8]. In the context of metabolic
engineering, models of metabolism play an important role in the simulation of
cellular behavior under different genetic and environmental conditions [22].
Typical experiments include knockout simulations to study how metabolic
flux distributions readjust throughout a given network. With the selection
of an optimal set of knockouts or changes in enzyme expression levels, it
is desirable to optimize the production of compounds of industrial interest
[1, 13].
Systems of ordinary differential equations (ODEs) have been applied in
different areas to model dynamical systems. In the context of metabolic net-
works, they describe the rate of change of metabolite concentrations. These
dynamic models contain rate law equations for the reactions as well as their
kinetic parameters and initial metabolite concentrations. Building this type
of model requires insight into enzyme mechanism to select appropriate rate
laws, as well as experimental data for parameter estimation. Therefore, their
application has been more limited, but areas of application include central
metabolic pathways of well-studied organisms such as E. coli [2] and S. cere-
visiae [14]. There are, however, some recent efforts to overcome these limi-
tations in the reconstruction of large-scale dynamic models, such as through
the hybrid dynamic/static approach [27], the ensemble modeling approach
[23], and the application of approximative kinetic formats using stoichiomet-
ric models as a scaffold [20, 7]. Nevertheless, these techniques have so far
been applied to very few organisms.
On the other hand, advances in genome sequencing have facilitated the re-
construction of genome-scale metabolic networks for several organisms, with
over 50 reconstructions available to date [12]. Due to the lack of kinetic data
at the genome scale, this type of model only accounts for reaction stoichiom-
etry and reversibility. Analysis is performed under the assumption of steady
state using a constraint-based formulation that is underdetermined, resulting
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in a continuous space of solutions for the reaction flux distributions. This un-
certainty of the flux distributions requires additional conditions to determine
unique solutions and predictions. Often this takes the form of an optimiza-
tion based on a particular assumption, such as optimal biomass growth for
wild-type [4] and minimization of cellular adjustments for knock-out strains
[18, 19]. The inclusion of regulatory constraints, introduced by [3], is a cur-
rent approach to reduce the size of the solution space and eliminate infeasible
solutions.
The two most common model types in use, therefore, represent two ex-
tremes. The dynamic ODE formulation contains detailed mechanistic infor-
mation that gives solutions of the transient dynamic approach to equilibrium
from any given set of initial conditions (generally concentrations of enzymes
and metabolites), as well as the steady state specified by metabolite concen-
trations that depend on total enzyme concentrations (for the usual case where
they are treated as fixed) but often do not depend on the initial metabolite
concentrations. Steady-state fluxes are readily computed from the steady-
state concentrations and the rate laws. The constraint-based formulation
seems minimalistic by comparison: it has no mechanistic knowledge of any
of the chemical reactions beyond their stoichiometry, its solutions have fluxes
at steady state, but no information regarding concentrations, or dynamics,
and rather than giving a unique solution, it produces a high-dimensional
continuum of steady-state solutions (referred to as the flux cone). The dy-
namic formulation needs significant information (parameters in term of rate
constants and total enzyme concentrations, as well as reaction mechanisms
to give rate laws), but generally rewards that effort with unique and detailed
solutions. The constraint-based formulation requires less (no parameters ex-
cept maximum fluxes) but delivers less.
Because of these significant differences between dynamic and constraint-
based formulations, they treat the effects of network perturbations that might
be undertaken as part of a metabolic engineering study very differently. A
dynamic formulation will make very specific predictions about the response
to a gene knockout, for example, but generally such models lack information
about gene regulatory changes that accompany metabolic changes, and so
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without foreknowledge to adjust relative enzyme concentrations, such pre-
dictions can be significantly in error. Constraint-based formulations can ac-
cess all possible steady-state solutions but can only rely on relatively simple
heuristics to select among them, and are uncertain how to include specific
information on gene regulatory changes.
Here we explore further the relationship between these formulations by
essentially considering the continuous ensemble of dynamic formulations ob-
tained by varying parameters (principally rate constants and enzyme con-
centrations) and compare the steady-state solutions to those from the cor-
responding constraint-based formulation. We find an equivalence between
the sets of steady states when only maximum flux constraints are present,
but that more specific constraints and enzyme concentrations can be directly
incorporated to define a reduced dynamic ensemble that is significantly more
informative regarding possible steady-state solutions than the constraint-
based formulation.
3.2 Methods
3.2.1 Models
We have used a dynamic model of the central carbon metabolism of E. coli
[2] available at the Biomodels database [9]. The model was converted from
its original SBML format into a MATLAB (The Mathworks; Natick, MA,
USA) file which was used for all the computations in this work. The model
consists of a total of 18 metabolites and 31 reactions, including several enzy-
matic reactions, one exchange reaction, and a few lumped versions of biosyn-
thetic pathways. Several types of rate laws are used, including constant rate,
mass-action, Hill cooperativity, allosteric regulation, and Michaelis-Menten
with its variants for reversibility and inhibition, with a total of 125 param-
eters. We have not considered metabolite dilution or algebraic rules for co-
metabolite variation, as they cannot be represented in the constraint-based
model. Also, we changed the rate law of MurSynth from constant rate to
Michaelis-Menten, as it leads to inconsistencies when its substrate (f6p) de-
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pletes. The model maintained its original steady-state despite these changes.
A constraint-based version of the model was built by accounting only for
the stoichiometry and reversibility constraints. The glucose uptake rate was
allowed to vary between 0 and the maximum value in the dynamic model.
The dynamic model also contains two other inputs (TrpSynth, MethSynth),
with a constant rate, that were considered in the constraint-based version
with constant fluxes.
3.2.2 Hit-and-Run sampler
We implemented an algorithm for random sampling (Fig. 3.1a) adapted to
this problem following the concept of hit-and-run methods [21]. The solution
space of the constraint-based model is contained within the null space of the
stoichiometric matrix. Starting with a point inside this coordinate space,
the sampler started generating new points by iterative steps in one direction.
Each point was then projected into the flux space and tested by checking the
flux boundary constraints. Each time the test failed, meaning that it crossed
the boundary of the flux cone, the point was discarded and a new direction
was randomly chosen. Otherwise, the point’s projection in the flux space was
stored. To facilitate uniform sampling of the whole space, the sampler only
stores one point every 1000 iterations. Also, in order to adapt to cones of
different sizes, it used a variable step size that increased (decreased) in case
of successful (failed) iterations, which quickly converged to an average size.
3.2.3 Geometric sampler
Given the poor results obtained by the hit-and-run method at the edges of
the cone, we designed and implemented a geometric sampler (Fig. 3.1b) that
started by searching the corners of the flux cone. It found the corners by solv-
ing linear programing problems within the model with randomized objective
functions using the GLPK library [11]. After finding the corners, it sampled
along all possible edges between the corners, which defined the bounds of
the cone. Then, it iteratively sampled from all edges in the direction of the
center of the cone, defined as the mean of all corners. This method facili-
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tated the visualization of the flux cone. However, in this case, the probability
distribution of the points did not have any statistical meaning.
3.2.4 Parameter sampler
Metabolite concentrations and kinetic parameters are theoretically defined
in an infinite semi-positive space. Therefore, in order to sample this type of
space without constraints, we scaled each element individually (concentration
or parameter) by a random factor with log-normal distribution (log10(X) ∼
N (0, 1)). This distribution is defined over R+, with nearly all values (99.73
%) within 3 orders of magnitude above or bellow unit. This resulted in
variation of the original values by several orders of magnitude. In order to
perform constrained parameter variation within well-defined ranges, specified
in terms of orders of magnitude (m), we scaled each parameter by a factor
with uniform distribution in logarithmic scale (log10(X) ∼ U(−m/2,m/2)).
All kinetic parameters associated with binding and rate constants were var-
ied, while other parameters such as Hill coefficients, co-metabolite levels and
dilution rate, were kept fixed.
3.2.5 Calculating steady states
For each simulation of the dynamic model, the steady state was calculated
by numerically integrating the differential equations from time zero toward
infinity with a stop condition when the steady state was reached. To avoid
non-halting computations when the system diverged or was oscillatory, a
second stop condition, based on a computational time limit, was also added.
3.2.6 Relative volume estimation
In order to estimate the volume of the cone after imposition of the kinetic
parameter constraints, we started by sampling the dynamic model under
those constraints. In this way the kinetic parameter ranges could be mapped
to flux ranges (Fig. 3.1e). Then, we used a random sample of the constraint-
based model (obtained with the hit-and-run sampler) and calculated the
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fraction of points of that sample that were contained within the generated
flux ranges. This fraction determined the relative volume of the subspace
compared to the original space [25].
3.3 Results
In order to explore the gap between both types of formulations, we analyzed
and compared the dynamic and constraint-based formulations of the same
model of the central carbon metabolism of E. coli [2] (see Methods section
for model formulation).
Our goal is to compare the steady states achievable by the two model
types. Intuitively the dynamic formulation has more constraints than the
constraint-based one because the later only enforces the steady-state condi-
tion and maximum flux constraints. Therefore, any set of steady-state fluxes
achieved by the dynamic formulation and that do not violate the maximum
flux constraints will automatically be a solution of the constraint-based for-
mulation. Thus, here we focus on mapping solutions in the opposite direction:
Is every solution of the constraint-based formulation also a steady-state so-
lution of the dynamic one? Or, instead, does the extra information in the
dynamic formulation effectively reduce the steady-state solution space so that
it is a proper subset of the constraint-based formulation.
3.3.1 Solution space of the constraint-based model
We implemented a Monte-Carlo based random sampler, which is a variation
of the hit-and-run method [21] (see Methods) and applied it to the constraint-
based model. The sampling distribution for each reaction (Fig. 3.2, diagonal)
forms skewed gaussian shaped curves, very similar to the results obtained by
[25] for the human red blood cell model. However, more insight into the
shape of the solution space can be revealed by plotting the sample two-
dimensionally for every pair of reactions (Fig. 3.2). It is possible to observe
that, due to the random nature of this method, the edges of the flux cone
are not sharply defined due to the low probability of samples in the tails of
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Figure 3.1: Overview of the methods applied in this work to the constraint-
based and the dynamic model. The solution space of the constraint-based
model has been sampled by (a) random sampling using a Hit-and-Run al-
gorithm, and (b) geometric sampling using the corners of the flux cone as
starting points. The solution space of the dynamic model has been sam-
pled by (c) varying the initial metabolite concentrations, and (d) the ki-
netic parameters. (e) By constraining the kinetic parameters of the dynamic
model we can delimit kinetically feasible flux regions and transfer them to
the constraint-based model.
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the gaussians. To obtain a clearer delineation of the borders of the space,
we implemented a geometric sampling approach that systematically identified
first the vertices of the flux cone through solution of linear programs, then the
edges through vertex connection, and finally explored the interior of the flux
cone (see Methods). The full solution space of the constraint-based model is
now clear (Fig 3.2), and it can be compared to that from the dynamic model.
3.3.2 Solution space of the dynamic model
Whereas the constraint-based model has no adjustable parameters, the dy-
namic model has a large number of parameters that describe the specific
chemistry being modeled, consisting of the rate laws, kinetic parameters (in
which we include a fixed total concentration for each protein), and initial
metabolite concentrations. This results in a single deterministic steady-state
solution. To examine how this solution is influenced by the extra informa-
tion, we varied the initial conditions and kinetic parameters, again by random
sampling (see Methods).
If the system has a unique steady state, then simulations will converge
to the same steady state, independent of the initial concentrations. This
network exhibits multistability; two distinct steady states were identified
when the initial concentrations of metabolites were varied (Fig. 3.3). This
bi-stability is caused by a positive feedback loop that is formed when phos-
phoenolpyruvate (PEP), a product of glycolysis, is used as an energy source
to import external glucose through the phosphotransferase system (PTS).
During the transient phase of the system, the concentration of PEP may
reach a critical level, where it gets depleted before re-entering PTS. If this
happens, the cell is unable to capture its external substrate, and all internal
metabolites eventually deplete as well, leading to a network with residual
activity. We can observe that this steady state (referred here as secondary)
occurs much less frequently than the steady state obtained with the original
conditions (Fig. 3.3, diagonal).
A random procedure was used to vary the kinetic model parameters, in-
cluding binding and rate constants (because all enzyme concentrations are
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Figure 3.2: Pairwise projection of the sampling of the constraint-based solu-
tion space using the hit-and-run sampler (blue) and the geometric sampler
(gray). The diagonal shows the probability distribution for each reaction
relative to the hit-and-run sampling. Only the first six reactions are shown.
Note that the gray points are plotted underneath the blue ones, and that the
geometric sampler delineates all of the space region covered by the hit-and-
run sampler, plus the additional spaces seen here.
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Figure 3.3: Pairwise projection of the sampling of the solution space obtained
for the dynamic model by sampling the initial metabolite concentrations,
overlapping the complete solution space (gray) for better visualization. The
dark blue dot shows the location of the original steady state. The red dot
shows the location of the secondary steady state. Only the first six reactions
are shown. The diagonal gives the relative probabilities of the steady-state
flux distribution.
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included in Vmax, which was varied, effectively enzyme concentrations were
varied as well), but not Hill coefficients, co-metabolite concentrations or the
dilution rate (see Methods). A single set of initial concentrations was used
(that for which the unperturbed model goes to the higher probability steady
state). A projection of the resulting steady-state concentrations shows that
the dynamic model, through parameter variation, appears to be able to pro-
duce the same steady states as the constraint-based model, but no additional
steady-states. This situation is tempered by two issues: (i) there are areas
of light coverage in Figure 3.4 that one presumes are truly occupied, and
(ii) even if the two-dimensional projection overlaps, this does not confirm
that the full-dimensional flux cones for the two models overlap. To more
stringently test the notion that the polytopes are identical, we generated a
procedure that would optimize parameters for the dynamic model to repro-
duce any desired steady-state solution (see Methods). We applied this to
10,000 randomly selected solutions from the constraint-based model and the
resulting parameters recovered the desired steady state when run in the dy-
namic model every time. Thus, operationally the steady-state flux cones for
ODE and constraint-based models are the same.
3.3.3 Kinetically feasible solution space
An ODE kinetic model of central carbon metabolism has exactly the same set
of possible steady-state solutions as the corresponding flux balance model,
as demonstrated in the previous section. The ODE model maps out the
solution space through systematic variation of model parameters (binding
constants, rate constants, and enzyme concentrations) with no constraints
beyond non-negativity. Knowledge of actual parameter values or ranges,
from experimental measurement or physical constraints, would lead to fur-
ther constraints on the feasible parameter space. To explore how constraints
on the feasible parameter space affect the range of steady-state solutions
achievable in the ODE kinetic model, we sampled parameter combinations
from constrained spaces and computed the steady states of the resulting
models. The fluxes in those steady states are plotted in Figure 3.5 for pa-
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Figure 3.4: Pairwise projection of the sampling of the steady-state solution
space for the dynamic model obtained by sampling the kinetic parameters.
The corresponding space overlaps the solution space given by the stoichio-
metric model (gray). The diagonal shows the probability distribution for
each reaction. Only the first six reactions are shown.
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rameter ranges from 100 up to 104-fold around the base parameter values.
The results show that parameter variation of 100-fold or greater appears to
produce the full set of steady-state flux solutions observed from the uncon-
strained non-negative parameters in the ODE model, which corresponds to
the flux-balance steady states. Parameter constraints leading to less than
100-fold variation produced significant restriction of the steady-state fluxes.
The solution-space volume reduction due to parameter constraints is plot-
ted quantitatively in Figure 3.6. The ratio of the solution flux cone with
constrained and unconstrained parameters is shown as a function of the con-
strained parameter ranges. The results (labeled “normal uptake”), show that
reduction of parameter uncertainty to a 10-fold range leads to a reduction
in the solution flux space to 10% of its unconstrained volume. Moreover,
because the size of the original space depends on a control variable of the
system, namely the glucose uptake rate, we increased glucose uptake from
1.28 mmol/gDW/h, the value in the original model, to 10.50 mmol/gDW/h,
the maximum value for E. coli under aerobic conditions [24]. The results,
shown in Figure 3.6 as “maximum uptake” show a similar sigmoid shape,
but shifted toward greater parameter variation. Under these condition, the
flux cone of solutions is reduced to 10% of its unconstrained volume with
300-fold parameter variation.
3.4 Discussion
We have analyzed and compared dynamic and constraint-based formulations
of the same model for the central carbon metabolism of E. coli [2]. The
constraint-based version does not account for metabolite concentrations, and
it does not express transient behavior. Therefore, the formulations can only
be compared at their common domain, which is the steady-state flux distri-
bution.
The constraint-based model defines a solution space for the steady-state
flux distribution (usually called the flux cone). This space is difficult to
visualize due to its high dimensionality. We addressed this problem by de-
veloping sampling and projection approaches that facilitate the visualization
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Figure 3.5: Pairwise projection, in heat-map form, of the solution space
reachable by the dynamic model as a function of the variation, in terms of
orders of magnitude, of the kinetic parameter space. The diagonal shows the
variation for each flux independently. Only the first six reactions are shown.
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Figure 3.6: Relative volume of the kinetically feasible solution space, com-
pared to the original space, as a function of the parameter variation, in terms
of orders of magnitude. The volume was calculated for the original glucose
uptake rate in the model and also for the maximum uptake rate.
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of the shape of solution space.
The steady state of the dynamic model contains the same constraints as
the constraint-based model (stoichiometry, thermodynamic reversibility, and
maximum uptake rates) and also any additional constraints imposed by the
kinetic rate laws, kinetic parameters, and initial metabolite concentrations.
Therefore, its solution space is a subset of the constraint-based solution space.
For a predefined set of initial conditions and parameter values, the dy-
namic model usually determines one steady-state solution. In fact, the ini-
tial metabolite concentrations of dynamic models determine their transient
behavior, but, for the steady-state flux determination, they serve only to
determine which steady-state is chosen in case of multiple stabilities in the
model. In this case, sampling the metabolite concentration space revealed a
second steady-state characterized by a flux distribution with lower values of
the fluxes and an accumulation of external glucose.
Instead, we also verified, as expected, that the location of the steady-state
solution(s) inside the solution space is determined by the kinetic parameters,
because by varying the kinetic parameters, the solution moves inside the
solution space. The sampling of the kinetic parameter space revealed that,
with unconstrained parameter values, the solutions of the dynamic model
cover the whole steady-state solution space. This overlapping may seem
unintuitive, as one would expect the rate laws to impose one additional layer
of constraint into the steady-state solution space. However, besides having
observed this with our sampling approaches, we also observe that, given any
valid steady-state flux distribution, one can find kinetic parameter values that
make the rate laws produce those steady state flux values by solving each
equation separately. This separation is only possible because the parameters
are specific for each rate law, which defines a partition over the parameter
set. The running example contains an average of 4 parameters per rate law,
yielding many degrees of freedom for each equation. Thus, it is not surprising
that, generally, parameter values can be found that satisfy the equations.
One interesting result is that, in general, tuning the maximum rate con-
stants is sufficient to make the rate laws fit any given steady-state flux. This
is valid for irreversible reactions given any metabolite concentrations. And,
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it is also valid for reversible reactions with the additional constraint that
the ratio between the given product and substrate concentrations exceeds
the equilibrium constant. In fact, the maximum rate constant is the only
parameter that the cell can control by adjusting the enzyme concentration
levels (recall that Vmax = kcat[E]0). This means that disregarding the details
of the transcriptional regulation (e.g. the fact that different genes share the
same transcription factor, or that same genes are associated with different
reactions) and the practical limitations in enzyme concentration, the cell can
in theory adjust its steady-state flux distribution within the admissible space
imposed by the topology of the metabolic network. This hypothesis reflects
the adaptability of the cell under different conditions and is in agreement
with the observations that microorganisms can undergo adaptive evolution
to attain their optimal theoretical yields when placed under conditions where
they originally performed sub-optimally [6].
The observations stated above show that, in theory, a dynamic model
can be fitted to any steady-state flux distribution inside the constraint-based
solution space. However, there are physical limitations to the values of the ki-
netic parameters. Also, by querying parameter databases such as BRENDA
[17] and SABIO-RK [16], it is possible to observe that for each kinetic param-
eter there is a range of possible values determined by experimental conditions
(such as temperature and pH) in which the cells are able to grow. There-
fore, we evaluated how the imposition of parameter ranges map into flux
ranges within the steady-state solution space. Although the rate laws do not
constrain the solution space by themselves, they influence the probability
distribution of the steady-state solutions. This is evidenced by the imposi-
tion of the kinetic parameter constraints. As the constraints become tighter,
the solutions of lower probability disappear and the reachable solution space
becomes smaller. Our results show that the impact of these constraints de-
pends on the size of the solution space of the genome-scale model, which is
mainly determined by the uptake rate of the limiting substrates, and on the
allowable ranges of the kinetic parameters in the dynamic model.
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3.5 Conclusions
In this work we have explored the solution spaces of both dynamic and
constraint-based models in order to bring together top-down and bottom-
up approaches, and we have proposed methods of treating each as well as
their interrelation.
Dynamic model reconstruction is a bottom-up approach for iteratively
building large-scale metabolic pathways with kinetic detail. Due to lack
of experimental data, differences in experimental conditions, and error prone
measurements, the kinetic parameters are often unavailable or defined within
certain ranges.
On the other hand, genome-scale reconstruction is a top-down approach
that takes advantage available high-throughput data to build models of metabolic
networks that account for stoichiometry and thermodynamic constraints.
These models are analyzed under a steady-state assumption through the
constraint-based approach. Furthermore, they can be iteratively refined by
imposition of new constraints that shrink the size of the solution space. One
such approach is the imposition of regulatory constraints, which can result
in significant reductions [3].
Taking advantage of the information available in dynamic models of cen-
tral pathways can increase the accuracy of genome-scale constraint-based
models by imposition of kinetic feasibility constraints even if the dynamic
model is not fully determined. Furthermore, sampling the solution space of
the dynamic model can be used as an experimental design tool to determine
which kinetic parameters have greater influence in defining the volume of the
solution space.
Increasing the accuracy of constraint-based models can influence sim-
ulation methods such as metabolic flux analysis (MFA) [26], flux balance
analysis (FBA) [4], minimization of metabolic adjustment (MOMA) [18] and
regulatory on/off minimization (ROOM) [19]. Tools that implement these
methods [15] can be extended to include kinetic constraints.
The constraint-based approach has been recently applied to other kinds of
biological networks, namely gene regulatory and signaling networks [5, 10].
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The availability of models for all kinds of networks will facilitate the cre-
ation of integrated cellular models that account for all types of intracellular
phenomena under the same mathematical framework. Because those mod-
els can be either constraint-based or dynamic, understanding relationships
between the two as discussed in this work will have an even greater impact.
In fact, although the use of common frameworks (either constraint-based or
dynamic) for representing different kinds of biological phenomena is a step
towards the use of integrated models, the development of tools that promote
the integration of the two most important representation frameworks is also
necessary for true integration. The current contribution is a step in that
direction.
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Chapter 4
A Framework for Model
Transformation
This chapter is based on the article “Model transformation of metabolic net-
works using a Petri net based framework” published at the International
Workshop on Biological Processes & Petri Nets (BioPPN 2010), Braga, Por-
tugal, 2010.
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Abstract
The different modeling approaches in Systems Biology create models with
different levels of detail. The transformation techniques in Petri net theory
can provide a solid framework for zooming between these different levels of
abstraction and refinement. This work presents a Petri net based approach to
Metabolic Engineering that implements model reduction methods to reduce
the complexity of large-scale metabolic networks. These methods can be
complemented with kinetics inference to build dynamic models with a smaller
number of parameters. The central carbon metabolism model of E. coli is
used as a test-case to illustrate the application of these concepts. Model
transformation is a promising mechanism to facilitate pathway analysis and
dynamic modeling at the genome-scale level.
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4.1 Introduction
Systems Biology provides a new perspective in the study of living systems
and embraces the complexity emerging of interactions among all biological
components. Combining theory and experiments, scientists build models to
explain and predict the behavior of the systems under study. Metabolic
Engineering is one of the fields where this perspective has proven useful
through the optimization of metabolic processes for industrial applications
[29, 2].
Modeling in Systems Biology is an iterative process as the life-cycle of a
model is comprised of successive refinements using experimental data. Dif-
ferent approaches, such as top-down, bottom-up or middle-out [18] are used
depending on the purpose of the model and the type of data available for its
construction. In Metabolic Engineering there are macroscopic kinetic mod-
els that consider the cell as a black-box converting substrates into biomass
and products, which are typically used for bioprocess control. On the other
hand, there are reaction-network-level models, either medium-scale dynamic
models with detailed kinetic information derived from literature and experi-
mental data [3], or genome-scale stoichiometric reconstructions derived from
genome annotation complemented with literature review [5].
Although the ultimate goal of Systems Biology is a complete understand-
ing of the cell as a whole, not only it is extremely difficult to collect all the
kinetic information necessary to build a fully detailed whole-cell model due
to the lack of experimental data and model identifiability concerns, but also
the computational cost of simulating the dynamics of a system with such
detail would be tremendous. Therefore, there is a need to fit the level of
detail of a model to the specific problem at hand. For instance, Metabolic
Pathway Analysis (MPA) has been useful in the analysis of metabolism as
a way to determine, classify and optimize the possible pathways throughout
a metabolic network. However, due to the combinatorial explosion of path-
ways with increasing number of reactions, it is still infeasible to apply these
methods in genome-scale metabolic reconstructions without decomposing the
network into connected modules [24, 25]. This zooming in and out between
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different levels of abstraction and connecting parts with different levels of de-
tail is a feature where formal methods and particularly Petri nets may play an
important role. Concepts such as subnetwork abstraction, transition refine-
ment or node fusion, among others, have been explored in Petri net theory
[8] and may provide the theoretical background for method development.
In previous work, we reviewed different modeling formalisms used in Sys-
tems Biology from a Metabolic Engineering perspective and concluded that
Petri nets are a promising formalism for the creation of a common framework
of methods for modeling, analysis and simulation of biological networks [15].
They are a mathematical and graphical formalism, therefore intuitive and
amenable to analysis. The different extensions available (e.g.: stochastic,
continuous, hybrid) provide the flexibility required to model and integrate
the diversity of phenomena occurring in the main types of biological networks
(metabolic, regulatory and signaling). Moreover, one may find biological
meaning in several concepts in Petri net theory; for instance, the incidence
matrix of a Petri net is the equivalent of the stoichiometric matrix, and the
minimal t-invariants correspond to the elementary flux modes (EFMs).
In this work, we explore strategies of model reduction for Petri net rep-
resentations of metabolic networks, and the integration of this methodology
with recent approaches such as genome-scale dynamic modeling. This chap-
ter is organized as follows. Section 4.2 explores the motivation for the work.
Section 4.3 presents the model reduction and kinetics inference methods, Sec-
tion 4.4 discusses their application to E. coli and Section 4.5 elaborates on
conclusions and future work.
4.2 Background
There are different examples of model reduction in the literature. One such
method was developed in [17], based on timescale analysis for classification
of metabolite turnover time using experimental data. The fast metabo-
lites are removed from the differential equations and their surrounding re-
actions are lumped. In [20] the EFMs of a reaction network are calculated
in order to create a macroscopic pathway network, where each EFM is a
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macro-reaction connecting extracellular substrates and products. A simple
Michaelis–Menten rate law is assumed for each macro-reaction and the pa-
rameters are inferred from experimental data. The method is applied in a
network with 18 reactions and a total of 7 EFMs. However it does not scale
well to larger networks because, in the worst case, the number of EFMs grows
exponentially with the network size.
The combinatorial pathway explosion problem is well known; there are
methods for network decomposition in the literature that address this issue.
In [24] the authors perform a genome-scale pathway analysis on a network
with 461 reactions. After estimating the number of extreme pathways (EPs)
to be over a million, the network is decomposed into 6 subsystems according
to biological criteria and the set of EPs is computed separately for each sub-
system. A similar idea in [25] consists on automatic decomposition based on
topological analysis. The metabolites with higher connectivity are considered
as external and connect the formed subnetworks. An automatic decomposi-
tion approach based on Petri nets is the so-called maximal common transition
sets (MCT-sets) [23], and consists on decomposing a network into modules by
grouping reactions by participation in the minimal t-invariants (equivalent
to EFMs). A related approach relies on clustering of t-invariants for network
modularization [9]. A very recent network coarsening method based on so-
called abstract dependent transition sets (ADT-sets) is formulated without
the requirement of pre-computation of the t-invariants and thus may be a
promising tool for larger networks [12].
Another problem in genome-scale metabolic modeling is the study of dy-
namic behavior. Genome-scale metabolic reconstructions are stoichiometric
and usually analyzed under steady-state assumption using constraint-based
methods, such as flux balance analysis (FBA) [1]. Dynamic flux balance
analysis (dFBA) allows variation of external metabolite concentrations, and
simulates the network dynamics assuming an internal pseudo steady-state at
each time step [16]. It is used in [19] to build a genome-scale dynamic model
of L. lactis that simulates fermentation profiles. However, this approach gives
no insight into intracellular dynamics, neither it integrates reaction kinetics.
In [27] the authors build a kinetic genome-scale model of S. cerevisiae us-
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ing linlog kinetics, where the reference steady-state is calculated using FBA.
Some of the elasticity parameters and metabolite concentrations are derived
from available kinetic models, while the majority use default values. Using
the stoichiometric coefficients as elasticity values is a rough estimation of the
influence of the metabolites on the reaction rates. Moreover, no time-course
simulation is performed. Mass action stoichiometric simulation (MASS) mod-
els are introduced in [14] as a way to incorporate kinetics into stoichiometric
reconstructions. Parameters are estimated from metabolomic data. Regu-
lation can be included by incorporating the mechanistic metabolite/enzyme
interactions. A limitation of these models is that mass-action kinetics do not
reflect the usual non-linearity of enzymatic reactions and the incorporation
of regulation leads to a significant increase in network size.
4.3 Methods
The idea of this work is closer to the reduction concepts of [17, 20] than
the modularization concepts in [24, 25]. In the latter cases a large model is
decomposed into subunits to ease its processing by analyzing the parts indi-
vidually. Instead, our objective is to facilitate the visualization, analysis and
simulation of a large-scale model as a whole by abstracting its components.
This reduction is to be attained by reaction lumping in a way that maintains
biological meaning and valid application of current analysis and simulation
tools. The Michaelis–Menten kinetics is a typical example of abstraction,
where the small network of mass-action reactions are lumped into one single
reaction.
The overall idea of the model reduction method is depicted in Fig. 4.1. A
large-scale stoichiometric model can be structurally reduced into a simplified
version that can be more easily analyzed by methods such as MPA. Also,
one may infer a kinetic structure to build a dynamic version of the reduced
model. Due to the smaller size, a lower number of parameters has to be
estimated. The data used for estimation may be experimental data found in
the literature, or pseudo-experimental data from dynamic simulations if part
of the system has been kinetically characterized.
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Figure 4.1: Overall concept of model reduction and kinetics inference.
When abstracting a reaction subnetwork into one or more macro-reactions,
it is important to consider the assumptions created by such abstraction. As
in Michaelis–Menten kinetics, these simplifications result in a pseudo-steady-
state assumption for the intermediate species that disappear. While this may
not be a problem for flux balance models, it changes the transient behavior
of dynamic models because the buffering effect of intermediates in a pathway
is neglected. The selection of metabolites to be removed depends on the
purpose of the reduction. The network may have different levels of granular-
ity based on the availability of experimental data, topological properties, or
simply in order to aggregate pathways according to biological function.
4.3.1 Basic definitions
The proposed method for model reduction uses several Petri net concepts
from the literature. We will use the following definition of an unmarked con-
tinuous Petri net (adapted from [4]) for modeling a stoichiometric metabolic
network:
Pn = < P, T, Pre, Post >
Pre : P × T → R+
Post : P × T → R+
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where the set of places P represents the metabolites, the set of transitions
T represents the reactions and Pre, Post are, respectively, the substrate and
product stoichiometries of the reactions. Note that for the representation of
a stoichiometric network, a discrete Petri net usually suffices; however, be-
cause some models may contain non-integer stoichiometric coefficients, the
continuous version was adopted. Moreover, we will assume that reversible re-
actions are split into irreversible reaction pairs. We will also use the following
definitions:
loc(x) ={x} ∪ •x ∪ x•
In(p) =
∑
t∈•p
Post[p, t] · v(t)
Out(p) =
∑
t∈p•
Pre[p, t] · v(t)
where •x, x• are sets representing the input and output nodes of a node x,
the set loc(x) ⊆ P ∪ T is called the locality of x, function v : T → R+0
is a given flux distribution (or the so-called instantaneous firing rate), and
In,Out : P → R+0 are, respectively, the feeding and draining rates of the
metabolites.
The method for network reduction consists of eliminating a set of se-
lected metabolites from the network. For each removed metabolite its sur-
rounding reactions are lumped in order to maintain the fluxes through the
pathways. This reduction assumes a steady-state condition for the metabo-
lite, i.e. In(p) = Out(p).
4.3.2 Model reduction: Conjunctive fusion
There are two options for lumping the reactions depending on the transfor-
mation method applied. The first approach is based on a transformation
called conjunctive transition fusion [8] and it results in an abstraction that
replaces the transition-bordered subnet loc(p) by a single macro-reaction.
The drawback of this method is that the flux ratios between the internal
reactions are lost. If a known steady-state flux distribution (v) is given,
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Figure 4.2: Exemplification of limit scenarios where all the internal metabo-
lites are removed. (A) In the conjunctive reduction case the result is one
single macro-reaction converting substrates into products with the respec-
tive yields specified in the stoichiometry. (B) In the disjunctive reduction
method, all possible pathways connecting substrates and products are enu-
merated.
then the stoichiometric coefficients can be adjusted to preserve the ratios for
that distribution; however, the space of solutions of the flux balance formu-
lation becomes restricted to a particular solution. In the limiting case, if
all the internal metabolites are removed, the cell is represented by one sin-
gle macro-reaction connecting extracellular substrates and products with the
stoichiometric yields inferred from the network topology for one particular
steady-state (Fig 4.2A). The transformation method for removing metabolite
p in Pn given a flux distribution v is described as follows:
Pn′ = < P ′, T ′, P re′, Post′ >
P ′ =P \ {p}
T ′ =T \ (•p ∪ p•) ∪ {tp}
Pre′ ={(pi, tj) 7→ Pre(pi, tj) | (pi, tj) ∈ dom(Pre) \ (P × (•p ∪ p•))}
∪{(pi, tp) 7→ fin(pi) | pi ∈ •(•p ∪ p•), pi 6= p, v′(tp) 6= 0, fin(pi) 6= 0}
Post′ ={(pi, tj) 7→ Post(pi, tj) | (pi, tj) ∈ dom(Post) \ (P × (•p ∪ p•))}
∪{(pi, tp) 7→ fout(pi) | pi ∈ (•p ∪ p•)•, pi 6= p, v′(tp) 6= 0, fout(pi) 6= 0}
v′ ={t 7→ v(t) | t ∈ T \ (•p ∪ p•)} ∪ {tp 7→ In(p)}.
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where
fin(pi) =
∑
t∈p•i∩(•p∪p•) Pre(pi, t) · v(t)
v′(tp)
fout(pi) =
∑
t∈•pi∩(•p∪p•) Post(pi, t) · v(t)
v′(tp)
The stoichiometric coefficients of the new reaction may be very high or low,
depending on v′(tp) and so, optionally, one may also normalize them with
some scalar λ, such that Pre′′(pi, tp) = 1λ · Pre′(pi, tp), Post′′(pi, tp) = 1λ ·
Post′(pi, tp) and v′′(tp) = λ · v′(tp). This will also make the final result
independent of the order of the metabolites removed. A good choice for λ is:
λ = max ({Pre(pi, tp) | pi ∈ •tp} ∪ {Post(pi, tp) | pi ∈ tp•})
4.3.3 Model reduction: Disjunctive fusion
The second approach is based on a transformation called disjunctive transi-
tion fusion [8], where every combination of input and output reaction pairs
connected by the removed metabolite is replaced by one macro-reaction. Al-
though this approach does not constrain the steady-state solution space of
the flux distribution, it has the drawback of increasing the number of transi-
tions, if the metabolite is highly connected, due to the combinatorial proce-
dure. Note that applying this reduction step to metabolite pi is equivalent to
performing one iteration of the t-invariant calculation algorithm to remove
column i of the transposed incidence matrix. Therefore, in the limiting case
where all internal metabolites are removed, the cell is represented by the
set of all possible pathways connecting extracellular substrates and products
(Fig. 4.2B), as was done in [20]. The definition, similar to the previous one,
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is as follows:
Pn′ = < P ′, T ′, P re′, Post′ >
P ′ =P \ {p}
T ′ =T \ (•p ∪ p•) ∪ {txy | (x, y) ∈ (•p× p•)}
Pre′ ={(pi, t) 7→ Pre(pi, t) | (pi, t) ∈ dom(Pre) \ (P × (•p ∪ p•)}
∪{(pi, txy) 7→ Pre0(pi, x) · Pre(p, y) + Pre0(pi, y) · Post(p, x)
| (x, y) ∈ (•p× p•), pi ∈ •{x, y}}
Post′ ={(pi, t) 7→ Post(pi, t) | (pi, t) ∈ dom(Post) \ (P × (•p ∪ p•)}
∪{(pi, txy) 7→ Post0(pi, x) · Pre(p, y) + Post0(pi, y) · Post(p, x)
| (x, y) ∈ (•p× p•), pi ∈ {x, y}•}
where
Pre0(p, t) =
Pre(p, t) if (p, t) ∈ dom(Pre)0 if (p, t) /∈ dom(Pre)
Post0(p, t) =
Post(p, t) if (p, t) ∈ dom(Post)0 if (p, t) /∈ dom(Post)
Whenever there are pathways with the same net stoichiometry, these can be
removed by checking the columns of the incidence (stoichiometric) matrix
and eliminating repeats. It should also be noted that in both methods, if
a metabolite acts both as substrate and product in a lumped reaction, it
will create a redundant cycle that is not reflected in the incidence matrix. If
these cycles are not removed, they propagate through the reduction steps;
therefore, they should be replaced by a single arc containing the overall
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stoichiometry. The procedure works as follows:
Pre′ ={(p, t) 7→ Pre(p, t) | (p, t) ∈ dom(Pre) \ dom(Post)}
∪{(p, t) 7→ Pre(p, t)− Post(p, t)
| (p, t) ∈ dom(Pre) ∩ dom(Post), P re(p, t) > Post(p, t)}
Post′ ={(p, t) 7→ Post(p, t) | (p, t) ∈ dom(Post) \ dom(Pre)}
∪{(p, t) 7→ Post(p, t)− Pre(p, t)
| (p, t) ∈ dom(Pre) ∩ dom(Post), Post(p, t) > Pre(p, t)}
The previous arc removing procedure may cause isolation of some nodes when
Pre(p, t) = Post(p, t); therefore, the isolated nodes should be removed:
P ′ = {p | p ∈ P, loc(p) 6= {p}}
T ′ = {t | t ∈ T, loc(t) 6= {t}}
4.3.4 Kinetics inference
Given a stoichiometric model, if metabolomic or fluxomic data are available
for parameter estimation, one may try to build a dynamic model by inferring
appropriate kinetics for the reactions. In [26] the authors propose that this is
performed by assuming linlog kinetics for all reactions using an FBA solution
as the reference state and the stoichiometries as elasticity parameters. An
integration of Biochemical Systems Theory (BST) with Hybrid Functional
Petri Nets (HFPN) is presented in [30], where general mass action (GMA) ki-
netics is assumed for each transition. The review of kinetic rate formulations
is out of the scope of this work and may be found elsewhere [10].
Assuming that all metabolites with unknown concentration were removed,
we will extend our definition to a marked continuous Petri net:
Pn =< P, T, Pre, Post,m0 >
where m0 : P → R+0 denotes the initial marking (concentration) of the
metabolites. The kinetics inference process consists on defining a firing rate
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v : T → R+0 , which will be dependent on the current marking (m) and the
specific kinetic parameters (see [7] for an introduction on marking-dependent
firing rates). As we assumed irreversible reactions, each rate will only vary
with substrate concentration. The rates can be easily derived from the net
topology. In case of GMA kinetics v is given by:
v(t) = kt
∏
p∈•t
m(p)ap,t
where kt is the kinetic rate of t and ap,t is the kinetic order of metabolite p
in reaction t. A usual first approximation for ap,t is Pre(p, t).
Linlog kinetics are formulated based on a reference rate v0, and defined
by:
v(t) = v0(t)
(
1 +
∑
p∈•t
ε0p,t ln
(
m(p)
m0(p)
))
where ε0p,t is called the elasticity of metabolite p in reaction t, reflecting
the influence of the concentration change of the metabolite in the reference
reaction rate. As in the previous case, Pre(p, t) can be chosen as an initial
approximation for ε0p,t. The relative enzyme activity term (e/e0) commonly
present in linlog rate laws to account for regulatory effects at larger time
scales will not be considered.
4.4 Results and Discussion
4.4.1 Central carbon metabolism of E. coli
The proposed methods were tested using the dynamic central carbon metab-
olism model of E. coli [3], where the stoichiometric part was used for the
application of the reduction methods, and the dynamic profile was used to
generate pseudo-experimental data sets for parameter estimation and vali-
dation of the kinetics inference method. A Petri net representation of this
model (Fig. 4.3) was built using the Snoopy tool [22]. All reversible reactions
were split into irreversible pairs. The net contains a total of 18 places, 44
transitions and is covered by 95 semipositive t-invariants, computed with the
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Integrated Net Analyzer [28].
In the application of the conjunctive method (Fig 4.4A), the metabolites
were classified as in [17] based on their timescale (Table 4.1), by calculating
their turnover time (τ : P → R+0 ) using the reference steady-state of the
dynamic model, where:
τ(p) =
m0(p)
In(p)
Metabolites with small turnover time are considered fast. In this case, all
metabolites except the slowest 5 (glcex, pep, g6p, pyr, g1p) were removed.
For the application of the disjunctive method (Fig 4.4B), the metabolites
were classified based on their topology (Table 4.1). We conveniently opted
to remove the metabolites with lower connectivity to avoid the combinatorial
explosion problem. All metabolites except 5 (g6p, pyr, f6p, gap, xyl5p) were
removed. This reduction assumes steady-state for the removed metabolites.
However, it makes no assumptions on the ratios between the fluxes, therefore
preserving the flux-balance solution space.
Because we are assuming that the reference steady-state is known, the
conjunctive reduced model was chosen for the application of the kinetics
inference method assuming linlog kinetics at the reference state. The elastic-
ity parameters were estimated using COPASI [13]. The pseudo-experimental
data was generated from simulation with the original model after a 1 mM ex-
tracellular glucose pulse with the addition of Gaussian noise (std = 0.05 mM)
(Fig. 4.5A). The fitted model was then validated using pseudo-experimental
data from a 2 mM pulse (Fig. 4.5B). It is possible to observe an instanta-
neous increase in pyr (from 2.67 to 3.93) and an instantaneous decrease pep
(from 2.69 to 1.26) which the model is unable to reproduce. The poor fitting
in some of the intracellular metabolites is expected given the significant re-
duction to the model. However, the extracellular glucose consumption profile
is remarkably good, both in the fitting and validation cases.
Although both reducing methods can be combined with kinetics inference,
the conjunctive version seems more suitable if a steady-state distribution is
known, because it generates smaller models, hence less parameters. The dis-
junctive version is appropriate for analyzing all elementary pathways between
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Figure 4.3: Petri net model of the dynamic central carbon metabolism model
of E. coli with reversible reactions split into irreversible pairs.
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Table 4.1: Metabolite topological properties: input reactions, output re-
actions, connectivity; and dynamic properties: concentration (mM), flux
(mM/s), turnover time (s) at the reference steady-state.
Metabolite #(•p) #(p•) #(•p× p•) m0 In τ
glcex 1 1 1 0.0558 0.0031 18.099
pep 1 6 6 2.6859 0.3031 8.8603
g6p 3 3 9 3.4882 0.2004 17.406
pyr 4 2 8 2.6710 0.2418 11.044
f6p 3 5 15 0.6014 0.1423 4.2266
g1p 1 2 2 0.6539 0.0023 278.62
pg 1 1 1 0.8092 0.1397 5.7929
fdp 2 1 2 0.2757 0.1414 1.9495
sed7p 2 2 4 0.2761 0.0454 6.0757
gap 7 6 42 0.2196 0.3661 0.5997
e4p 2 3 6 0.0986 0.0454 2.1684
xyl5p 3 3 9 0.1385 0.0839 1.6503
rib5p 2 3 6 0.3994 0.0558 7.1626
dhap 2 3 6 0.1682 0.1414 1.1892
pgp 2 2 4 0.0080 0.3207 0.0251
pg3 2 3 6 2.1437 0.3207 6.6851
pg2 2 2 4 0.4014 0.3031 1.3241
ribu5p 3 2 6 0.1114 0.1397 0.7974
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Figure 4.4: Reduced versions of the original network. (A) Conjunctive re-
duction method. (B) Disjunctive reduction method.
Figure 4.5: (A) Results of parameter estimation with pseudo-experimental
data with 1 mM extracellular glucose pulse. (B) Validation of the model with
a 2 mM extracellular glucose pulse. In both cases, the circles represent the
experimental data and the lines represent time-course simulations generated
by the reduced model.
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a set of metabolites without the burden of calculating the set of EFMs of the
whole model. For instance, the macro-reactions M4 (ALDO + G3PDH ) and
M5 (ALDO + TIS ), with net stoichiometries of, respectively, [fdp → gap]
and [fdp → 2 gap], are two unique pathways between these two metabolites.
4.4.2 Transforming a genome-scale model
In order to test the proposed framework at the genome-scale level, we used
a genome-scale metabolic model of E. coli [21], which includes 625 metabo-
lites and 931 biochemical reactions. Genome-scale models can be simulated
using FBA, but the results are hard to visualize graphically, and they do not
provide a suitable starting point for inferring kinetic models, due to the com-
plexity of the generated models. However, a reduced version of this model
would provide a suitable scaffold for building a dynamic model. The dis-
junctive method is not feasible at the genome scale due to its combinatorial
nature. Therefore, the conjunctive approach is clearly the only option in this
case.
As a proof of concept, we created a reduced genome-scale model that
preserves all the metabolites and reactions in common with the dynamic
central carbon model. The remainder intermediate metabolites are removed,
resulting in a lumped version of all other metabolic pathways. Note that
some of the reactions on the central carbon model already represent lumped
versions of some biosynthetic pathways (e.g. mursynth, trpsynth, methsynth,
sersynth). However they were not deduced from the genome-scale network
and may not be accurate abstractions of these pathways. An FBA simulation
of the genome-scale model was performed in order to obtain the reference
steady-state flux distribution, where the fluxes of the common reactions were
constrained to their reference value in the central carbon model. Figure 4.6
shows the resulting condensed network. The nomenclature and visual layout
from the central carbon model was preserved in order to facilitate comparison.
It is possible to observe that almost all reactions that are not part of the
central carbon metabolism were lumped together with the biomass reaction
to form a lumped macro-reaction that reflects the contribution of all internal
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metabolites to the biomass formation. This picture also expresses the how the
external substrates and products contribute to the overall metabolic activity.
4.5 Conclusions
This work presents strategies for model reduction of metabolic networks
based on a Petri net framework. Two approaches, conjunctive and disjunctive
reduction are presented. The conjunctive approach allows the abstraction of
a subnetwork into one lumped macro-reaction, however limited to one par-
ticular flux distribution of the subnetwork. The disjunctive approach on the
other hand, makes no assumptions on the flux distribution by replacing the
removed subnetwork with macro-reactions for all possible pathways through
the subnetwork, therefore not constraining the steady-state solution space.
In both cases, the reduced model may be transformed into a dynamic model
using kinetics inference and parameter estimation if experimental data is
available. Using the reduced model, instead of the original, facilitates this
process because it significantly decreases the number of parameters to be
estimated.
We have shown how our framework can be applied in the creation of
condensed genome-scale metabolic models that preserve the stoichiometry of
the original models. In future work, we intend to create a dynamic model
based on the generated condensed model. This model can reuse all the
information already available in the dynamic central carbon. It will only
be necessary to find suitable rate laws and kinetic parameters for the new
reactions in the model.
Among the extensions available to Petri nets are the addition of different
types of arcs, such as read-arcs and inhibitor-arcs, which could be use to
represent activation and inhibition in biochemical reactions. They could also
be used to integrate metabolic and regulatory networks. Optimization in
metabolic processes is usually based on knockout simulations in metabolic
networks. However, these simulations do not take into consideration the
possible regulatory effects caused by the knockouts. In our transformation
methods we removed the arcs with the same stoichiometry in both directions,
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Figure 4.6: Condensed version of the genome-scale metabolic model of E.
coli, extending the previous example of the central carbon model. To avoid
saturating the image, the participation of the cofactors in most of the re-
actions is not represented. The stoichiometric coefficients of the biomass
reaction are also not displayed. The reaction is the following: glcex + 6.21
pep + 29.3 pyr + 0.72 f6p + 0.218 g1p + 0.277 sed7p + 0.0769 rib5p + 0.03
dhap + 38.2 pg3 + 0.462 ribu5p + 669 atp + 251 nadph + 238 nadh + 1.88
glyc3p + 10.3 prpp + 5.45 2dda7p + 2.56 so4(e) + 59.1 accoa + 64.8 h2o +
1.69 adpglc + 1.95e+03 h + 25.3 oaa + 236 o2(e) + 118 nh4(e) + h2o(e) →
0.522 gap + 655 adp + 15 amp + 251 nadp + 238 nad + 59.1 coa + glcn(e)
+ 35.2 ppi + 90.7 co2 + 0.934 phe L(e) + 2.1e+03 h(e) + 687 pi .
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Figure 4.7: Reduction step conserving the read-arcs associated with the en-
zymes of the original reactions.
because these are not reflected in the stoichiometric matrix. In the Michaelis–
Menten example this results in removing the enzyme from the network. The
proposed methods can be extended to consider read-arcs for these situations,
which should be preserved during the reduction steps, therefore establishing
connection places to the integration of a regulatory network (Fig 4.7).
An alternative to the reduction of the models would be to consider their
representation using hierarchical Petri nets. In this case, each macro-reaction
would be connected to its detailed subnetwork. Although this would not re-
duce the number of kinetic parameters in the case of kinetics inference, it
would be extremely useful for facilitated modeling and visualization of large-
scale networks without compromising detail. It could also be the solution
for genome-scale pathway analysis, if it is performed independently at each
hierarchical level. The hierarchical model composition proposed for SBML
[6] may facilitate the implementation of this alternative. See [11] for an auto-
matic network coarsening algorithm based on hierarchical petri nets applied
to different kinds of biological networks.
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Chapter 5
Accounting for Enzymatic
Regulation
This chapter is based on the article “Accounting for enzymatic regulation in
large-scale kinetic reconstructions of metabolism” (in preparation).
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Abstract
The current limitations in constraint-based models and mechanistic kinetic
models of metabolism are leading to new approaches for building kinetic
models at the genome-scale. These models are built by combining constraint-
based models and approximative kinetic formats. However, they lack the
effects of enzymatic regulation, as it is not accounted for in the underlying
network topology. In this work, we propose the utilization of Extended Petri
nets as scaffold for the generation of large-scale kinetic models in order to
account for enzymatic regulation during the kinetic inference process. We
generate kinetic models for the central carbon metabolism of E. coli, with and
without enzymatic regulation. We then evaluate the impact of accounting
for this kind of regulation in metabolic reconstructions by performing several
knockouts and changes in enzyme expression levels and comparing the results
with those generated with the original dynamic model of this pathway. Our
results show that accounting for enzymatic regulation has an influence on the
determination of the steady-state flux distribution of mutants, and allows
the prediction of changes that would otherwise be unforeseen. We conclude
that the inclusion of enzymatic regulation in metabolic reconstructions is an
important step that can be performed if flexible model representations like
Petri nets are applied, and it can be used to reveal new manipulation targets
for strain optimization
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.5.1 Introduction
During the past years, Systems Biology has pushed the frontier of our under-
standing of the complex phenomena of life, with the creation of mathematical
and computational models of the cell [24]. The predictive capability provided
by these models is fundamental for the improvement of several areas such as
biomedical research and industrial biotechnology. In particular, the field of
Metabolic Engineering [51], takes advantage of mathematical models of cel-
lular metabolism, in order to discover optimal sets of genetic manipulations
for the design of mutant microbial strains that efficiently produce compounds
of industrial interest [4, 34].
One of the current approaches for modeling metabolic pathways is the
development of mechanistic kinetic models based on systems of ordinary dif-
ferential equations (ODEs). This kind of models includes detailed kinetic
rate laws that describe the details of the enzymatic mechanisms and usually
contain several kinetic parameters. Due to the large amount of experimen-
tal data required to estimate these parameters, this modeling approach has
been limited to central pathways of well-studied organisms, such as E. coli
[8] and S. cerevisiae [40]. On the other hand, constraint-based modeling is
an alternative approach that describes the admissible steady-state flux dis-
tributions in terms of stoichiometric and thermodynamic constraints. Given
the simplicity in the formulation, and the fact that no kinetic parameters are
required to instantiate this kind of models, they have been applied in most
genome-scale metabolic reconstructions [39, 36].
Although constraint-based models have a clear advantage in terms of scal-
ability when compared to kinetic models, they contain several limitations.
Besides not describing intracellular transient behavior, they do not take into
account metabolite concentration and enzymatic regulation effects. To over-
come the limitations of both approaches, a more recent approach is emerging
[49, 50, 22]. It consists on the automatic generation of approximative ki-
netic models, using constraint-based models as a scaffold. Approximative
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kinetic formats abstract from the enzymatic mechanism details, hence they
usually require fewer parameters than mechanistic rate laws [19]. Therefore,
this kind of models can scale to larger metabolic networks when compared
to mechanistic models. Also, they determine a single solution rather than a
space of solutions, and they are able to integrate high-throughput data from
several omics (proteomics, fluxomics and metabolomics).
The rate of a reaction can be controlled at the gene regulatory level by
controlling the amount of enzyme that is produced (transcriptional regula-
tion), and also by regulating enzyme activity through metabolic activators
and inhibitors (enzymatic regulation). Gene regulatory networks operate at
a larger time-scale than metabolic networks, therefore enzyme concentration
is usually considered constant in metabolic models. However, enzymatic reg-
ulation is part of the metabolism itself and it is responsible for the regulation
of many metabolic pathways. A current limitation in the process of generat-
ing kinetic models from constraint-based models is the fact that the later do
not express the enzymatic regulation relationships between metabolites and
enzymes.
Petri nets are a graphical and mathematical formalism that have been
applied in the modeling of several biological pathways, including metabolic
[38, 27, 57, 26], gene regulatory [6, 7], and signaling [43, 9, 3, 18]. They are
very similar to the constraint-based formulation of metabolic models, as they
both determine the topology of the network in terms of consumption and pro-
duction of metabolites. Extended Petri nets are extensions to the original
formalism that include special types of arcs that model the effect of com-
ponents that participate in a process without being consumed or produced
[10, 1].
In this work we propose the utilization of Extended Petri nets as a scaffold
for the kinetic inference process, in order to build large-scale kinetic recon-
structions that account for enzymatic regulation. We test the potential of this
approach by generating a kinetic model of the central carbon metabolism of
E. coli and evaluating the impact of enzymatic regulation in the prediction of
mutant phenotypes by comparing with the simulation results obtained from
the available dynamic model for this organism that as been experimentally
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validated [8]. See Fig. 5.1 for an overview of our proposed procedure.
5.2 Methods
5.2.1 Central carbon metabolism model of E. coli
In order to evaluate the predictive capabilities of the models automatically
generated by kinetic inference, we used a published and validated dynamic
model of the central carbon metabolism of E. coli as reference [8]. The model
is available in SBML format [21] at the Biomodels database [29]. It contains
a total of 18 metabolites and 31 reactions, including several enzymatic re-
actions, one exchange reaction and a few lumped versions of biosynthetic
pathways, holding a total of 125 kinetic parameters. We did not consider
metabolite dilution and the contribution of cofactors both to the topology
and dynamics of the network.
The model’s topology was used to build the topology of the Petri net
models used in this work. The enzymatic regulation effects present in the
kinetic equations were used to define the topology of the regulatory inter-
actions in the Extended Petri net model. The original model was also used
to generate pseudo-experimental data, both for parameter estimation and
validation of results.
5.2.2 Petri net models
Petri nets are bipartite graphs with two types of nodes, places and transi-
tions that, within the biochemical context, respectively represent substances
and reactions. Arcs between places and transitions define consumption and
production relationships. The notation to define Petri nets can vary among
the literature. We will adopt the following definition (adapted from the def-
inition of an unmarked generalized Petri net of [15]). A Petri net (Pn) is a
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Figure 5.1: Overview of the main steps of a metabolic model reconstruc-
tion process: Genome annotation and literature data are used to reconstruct
metabolic networks; using Extended Petri nets as a scaffold, rather than sim-
ple Petri nets or constraint-based models, allows the inclusion of enzymatic
regulation; the kinetic inference uses the network’s topology to build a ki-
netic model, using experimental data for parameter estimation; the kinetic
models can be used for time-course and steady-state simulation; optimiza-
tion methods can be used to find optimal targets for rational strain design.
This work focuses only on the kinetic inference and simulation steps (dark
arrows).
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4-tuple:
Pn = < P, T, Pre, Post >
Pre : P × T → N
Post : P × T → N
where P is the set of places, T is the set of transitions, Pre and Post are the
arcs representing, respectively, substrate and product stoichiometries.
We created a Petri net model based on the topology of the original dy-
namic model. The model is able to account for the stoichiometric information
that is present in the original model. However, because transitions are uni-
directional, the reversible reactions are decomposed into irreversible reaction
pairs. This model is essentially equivalent to a constraint-based model (with-
out flux capacity constraints).
Extended Petri nets are extensions to the original Petri net formalism,
that include special types of arcs, such as activator (also know as read or test)
and inhibitor arcs [10, 1]. In the biochemical context these arcs represent
regulatory interactions that modulate enzymatic activity. We will use the
following definition of an Extended Petri net (En):
En = < P, T, Pre, Post, A, I >
Pre : P × T → N
Post : P × T → N
A : P × T → N
I : P × T → N
where P, T, Pre, Post have the same meaning as in the previous case, and A, I
respectively represent activator and inhibitor arcs. We will use the following
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notation:
•r = {p | p ∈ P, (p, t) ∈ dom(Pre)}
t• = {p | p ∈ P, (p, t) ∈ dom(Post)}
↑t = {p | p ∈ P, (p, t) ∈ dom(A)}
↓t = {p | p ∈ P, (p, t) ∈ dom(I)}
to respectively represent the sets of substrates, products, activators and in-
hibitors of a reaction modeled by transition t.
Similarly to the previous case, we created an Extended Petri net model
based on the original dynamic model. However, in this case, the model not
only accounts for the stoichiometry but also for the enzymatic regulation
relationships that exist in the original model. Figure 5.2 shows a graphical
representation of the model, built with the Snoopy Petri net editor [41]. It
is possible to observe a regulatory layer that is not considered in the simple
Petri net model (or equivalently, in a constraint-based model).
5.2.3 Kinetic inference
The kinetic inference process consists on the generation of kinetic rate laws
for the reactions in the model and the instantiation of the kinetic param-
eters and the initial metabolite concentrations. Approximative kinetic for-
mats facilitate this process as they do not require insight into the enzymatic
mechanism details. Commonly used formats include generalized mass action
(GMA) [20], lin-log [55], and convenience kinetics [31]. For a review in this
topic see [19].
Within the Petri net framework, the kinetic inference process can be
performed by a transformation from the discrete Petri net model into a con-
tinuous Petri net. We will adopt the following definition of a continuous Petri
net (adapted from the definition of a marked continuous Petri net of [15]).
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Figure 5.2: Petri net representation of the central carbon metabolism model
of E. coli built with the Snoopy Petri net editor [41]. Reversible reactions are
decomposed into irreversible pairs. Edges with arrows represent production
and consumption of metabolites. Edges with closed circle (red) and edges
with open circle (green), respectively represent activation and inhibition.
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A continuous Petri net (Cn) is a 6-tuple:
Cn = < P, T, Pre, Post,m0, v >
Pre : P × T → R+
Post : P × T → R+
m0 : P → R+
v : T → R+
where P, T, Pre, Post represents the network topology of the discrete Petri
net, m0 is the initial metabolite concentration and v is the firing rate function,
which is defined according to the approximative kinetic format chosen. In
this case, we have adopted the GMA format:
v(i) = ki
∏
j∈•i
(
m(j)fj,i
)
where ki is the kinetic rate of reaction i and fj,i is the kinetic order of metabo-
lite j in reaction i. The Extended Petri net version can also be mapped into
a continuous version, by adopting the following definition:
Cn = < P, T, Pre, Post, A, I,m0, v >
Pre : P × T → R+
Post : P × T → R+
A : P × T → R
I : P × T → R
m0 : P → R+
v : T → R+
where all the elements have the same meaning as in the previous case. How-
ever, in this case the firing rate function needs to take into consideration
the regulatory effects of the activator and inhibitor arcs. We adopted the
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multiplication by a regulatory factor as suggested in [44]:
v(i) = ki
∏
j∈•i
(
m(j)fj,i
)∏
j∈↑i
(
m(j)
KA,j +m(j)
)∏
j∈↓i
(
KI,j
KI,j +m(j)
)
where KA,j and KI,j respectively represent activation and inhibition con-
stants. Note that when KI → ∞ (never inhibited) and KA → 0 (always
active) the regulatory model is equivalent to the non-regulatory model.
5.2.4 Parameter estimation
After generating the kinetic models it is necessary to estimate the values of
the kinetic parameters. We used the original dynamic model to generate
steady-state fluxomic and metabolomic data. For the reversible reactions,
the flux was decomposed into forward and reverse rates. These data were
used to estimate the kinetic parameters in both models. For the kinetic order
parameters it is common to assume the stoichiometry of the metabolite as
default value [49, 12]. Therefore, in the non-regulatory model, given the
steady-state fluxes (vss) and metabolite concentrations (mss), we can estimate
the kinetic rate constants for each reaction i as :
ki =
vss(i)∏
j∈•i (m(j)
Pre(j,i))
.
The case is different for the regulatory model, as there can be many parame-
ters per equation. We opted to set a default value of 1 mM for all regulatory
constants to be in the same order of magnitude as the metabolite concentra-
tions. Again, the kinetic constants can be calculated from the given data:
ki =
vss(i)∏
j∈•i (m(j)
Pre(j,i))
∏
j∈↑i
(
m(j)
KA,j+m(j)
)∏
j∈↓i
(
KI,j
KI,j+m(j)
) .
5.2.5 Simulation
Our models are generated using our code and stored in SBML format. Note
that in SBML there is no distinction between activation and inhibition as all
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regulators are simply referred to as modifiers. We circumvented this problem
by manually adding annotations to the reactions with this information, which
are then recognized by our kinetic generation code. This problem is also
discussed in [16] where the authors suggest the utilization of Systems Biology
Ontology (SBO) [28] to annotate the models.
For simulation purposes, the SBML files are converted to Matlab files,
and we use Matlab’s ode15s function to integrate the generated system of
ordinary differential equations (ODEs). The integration is performed in the
time range of zero to infinity, with additional conditions to stop the compu-
tation when the system reaches a steady-state or to abort when it exceeds
a given CPU utilization time limit. Knockouts and changes in enzyme ex-
pression levels are simulated by premultiplying the respective equations with
a factor (e/e0). After simulation, the fluxes of the decomposed reversible
reactions are combined in order to facilitate comparison with the original
model.
5.3 Results
We evaluated the predictive capability of the generated models to determine
mutant phenotypes, by performing single knockouts of the enzymes in the
model. We tested both the regulatory and non-regulatory models and com-
pared with the pseudo-experimental data generated with the original model.
We also tested under and over-expression of enzyme concentration levels by
5-fold decrease and increase, respectively. Table 5.1 shows the results of the
simulations given by the error (ε) of the steady-state flux distribution of the
mutant (vm) compared to the pseudo-experimental data generated with the
original model under the same perturbation (v∗m), normalized by the wild-
type flux distribution (v∗w):
ε =
||vm − v∗m||
||v∗w||
.
In both models it is possible to observe a low error for most mutations.
However, in the cases with higher errors, there is no clear dominance of any
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Table 5.1: Normalized errors of the simulations performed with the non-
regulatory (-r) and regulatory (+r) models, for all single enzyme perturba-
tions including knockout (KO), under-expression (UE) and over-expression
(OE). In some cases (*) the simulation could not reach a steady-state.
Enzyme KO (-r) KO (+r) UE (-r) UE (+r) OE (-r) OE (+r)
PGI 0.010 0.010 0.000 0.000 0.000 0.000
PGM 0.003 0.003 0.001 0.001 0.000 0.000
G6PDH 0.024 0.024 0.019 0.022 1.112 1.080
PFK 0.018 0.021 0.478 0.361 0.230 0.219
TA (*) (*) 0.005 0.004 0.001 0.001
TKA 0.379 0.816 0.006 0.006 0.001 0.001
TKB (*) 0.048 0.004 0.002 0.001 0.000
ALDO (*) (*) 0.003 0.024 0.000 0.006
GAPDH 0.005 0.005 0.080 0.098 0.037 0.203
TIS 0.036 0.100 0.002 0.020 0.000 0.005
G3PDH 0.002 0.001 0.002 0.001 0.009 0.005
PGK 0.005 0.005 0.002 0.002 0.000 0.000
PGluMu 0.005 0.005 0.001 0.001 0.000 0.000
ENO 0.005 0.005 0.001 0.001 0.000 0.000
PK 0.049 0.029 0.041 0.021 0.134 0.059
PEPC 0.095 0.035 0.066 0.023 0.092 0.053
DAHPS 0.022 0.008 0.017 0.006 0.044 0.033
PDH 1.011 1.010 0.147 0.147 0.060 0.060
PGDH (*) (*) 0.000 0.000 0.000 0.000
R5PI (*) (*) 0.010 0.008 0.002 0.002
Ru5P 0.377 0.823 0.012 0.010 0.002 0.002
PPK 0.012 0.012 0.010 0.009 0.035 0.020
G1PAT 0.003 0.003 0.002 0.002 0.011 0.009
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Figure 5.3: Comparison of the steady-state flux distributions (mM/s) of the
generated models (“Non-Reg”, “Regulatory”) with the pseudo-experimental
data (“Wildtype”, “Mutant”) after knockout of: G6PDH (left side), PDH
(right side).
of the models over the other.
In some of the knockout mutations the simulations were not able to reach
a steady-state. This happened in both models with the exception of the
knockout of TKB, where the simulation was able to reach a steady-state in
the regulatory model but not in the non-regulatory one. In Figures 5.3–5.5
it is possible to observe some cases that will be analyzed in more detail.
The knockout of G6PDH was predicted with great accuracy by both
models (Fig. 5.3). In this case, the flux from G6PDH is redirected through
PGI. It is possible to observe an inversion in the fluxes of Ru5P and TKB,
which were correctly predicted in both cases.
The knockout of PDH resulted in a blocked metabolism that does not
carry any flux (Fig. 5.3). This is a consequence of an accumulation of pyru-
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Figure 5.4: Comparison of the steady-state flux distributions (mM/s) of the
generated models (“Non-Reg”, “Regulatory”) with the pseudo-experimental
data (“Wildtype”, “Mutant”) after under-expression (0.2×) of: PEPC (left
side), PFK (right side).
vate which causes the inhibition of PTS. This inhibition is only temporary
but is however sufficient to allow a depletion of pep by drain reactions, break-
ing the cycle where it re-enters in PTS. We would expect this consequence
to be predicted by the regulatory model. However, due to the fact that we
have adopted GMA kinetics, the model does not account for the saturation
of Synth2, which was able to completely consume the excess of pyruvate.
The under-expression of PEPC caused a redirection of a small part of the
flux from glycolysis to the pentose-phosphate pathway (Fig. 5.4). This was
correctly predicted by the regulatory model but not by the non-regulatory
model. The reason is that the accumulation of pep causes the inhibition of
PFK and consequently a decrease in the whole glycolytic pathway, favoring
the pentose-phosphate pathway.
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Figure 5.5: Comparison of the steady-state flux distributions (mM/s) of the
generated models (“Non-Reg”, “Regulatory”) with the pseudo-experimental
data (“Wildtype”, “Mutant”) after over-expression (5×) of: GAPDH (left
side), PK (right side).
The under-expression of PFK has an effect similar to the previous case
(Fig. 5.4). However, in this case both models predict an exaggerated re-
sponse to the redirection of the flux, with an inversion of PGI coupled with
a substantial flux increase in all the reactions of the pentose-phosphate path-
way.
The over-expression of GAPDH was one of the cases where the regula-
tory model had a larger error than the non-regulatory model (Fig. 5.5). In
this case there was a small shift of the flux from glycolysis to the pentose-
phosphate pathway. The non-regulatory model did not account for this shift,
whereas the regulatory model had an exaggerated response and incorrectly
predicted an inversion of PGI.
The over-expression of PK resulted in a shift of the flux from the pentose-
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phosphate pathway to the glycolytic pathway (Fig. 5.5). One of the causes
for this change is that PK was one of the bottlenecks in this pathway. In
this case the regulatory model predicted the resulting steady-state in good
agreement with the pseudo-experimental data, whereas the non-regulatory
model failed to predict these changes.
5.4 Discussion
5.4.1 Advantages of kinetic modeling
The construction of kinetic models of metabolism has been limited by the
amount of experimental data required to describe in detail the enzymatic
mechanisms and to estimate their respective kinetic parameters. Instead,
constraint-based modeling has become the de facto framework for modeling
the metabolism at the genome scale. However, there are several limitations
with this approach, such as not accounting for metabolite concentrations,
not defining a single steady-state solution and not describing transient be-
havior. The increasing availability of omics data (proteomics, metabolomics,
fluxomics) is driving the development of new approaches for kinetic modeling
at the genome scale.
Mass action stoichiometric simulation (MASS) models were introduced in
[22]. It is a modeling approach that consists on adding mass action kinetics
to a stoichiometric network and using metabolomic and fluxomic data to
estimate the kinetic parameters. The method was tested on a stoichiometric
reconstruction of the human red blood cell model. The authors also evaluate
the impact of enzymatic regulation by adding the regulatory interactions
to the model. However, this requires the decomposition of each enzymatic
mechanism into its elementary steps, which more than doubled the size of
the network. This decomposition step is avoided in our approach by the
introduction of regulatory arcs.
In [50] the authors built a genome-scale kinetic model of S. cerevisiae.
Using the available constraint-based as a scaffold, they generated a kinetic
model using lin-log kinetics. The reference steady-state flux distribution is
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found with the constraint-based model using flux balance analysis and the
stoichiometric coefficients are used as estimates of the elasticity parameters.
Since this kinetic model is based on the underlying constraint-based model,
it does not account for enzymatic regulation.
There are advantages in using kinetic rather than constraint-based mod-
els for steady-state simulation. First, they define an unique steady-state
solution. In this manner, it is possible to calculate the steady-state phe-
notype of mutants without requiring any extra assumptions, which is the
case in constraint-based methods such as flux balance analysis (FBA) [54],
minimization of metabolic adjustment (MOMA) [46] and regulatory on/off
minimization (ROOM) [47]. Also, it is possible to account for the enzyme
expression levels in a straightforward manner. In previous work we analyzed
how the inclusion of proteomic data in kinetic models can improve the sim-
ulation of knockout strains [11]. There are some approaches to account for
enzyme expression levels in simulations of constraint-based models, but their
formulation is not straightforward and usually requires the introduction of
new assumptions or the inclusion of a considerable amount of experimental
data [35, 56, 53].
5.4.2 The effects of enzymatic regulation
In this work we propose a new approach for large-scale kinetic reconstruction
that accounts for enzymatic regulation. We evaluate the impact of accounting
for this kind of regulation in metabolic reconstructions by generating kinetic
models with and without regulation and comparing the results with those
obtained from the original dynamic model of the central carbon metabolism
of E. coli [8]. In particular, we evaluate the effect of enzymatic regulation in
the determination of the steady-state flux distribution of mutant strains by
performing enzyme knockouts and changes in expression levels.
Our results show that enzymatic regulation has an influence on the steady-
state flux distribution obtained with the kinetic model. We can observe that
there is not a clear gain in the precision of the predictions. This is most likely
due to the fact the regulatory model has more parameters than the non-
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regulatory model, which were given a default value rather than estimated.
Nonetheless, it is possible to observe that in some cases there were changes in
the flux distribution which could not be predicted without accounting for the
regulatory effects (e.g.: under-expression of PEPC, over-expression of PK ).
Along with simulation, metabolic models are also used for optimization
purposes. Optimization algorithms search for optimal modification targets in
order to improve the production of compounds of industrial interest [4, 34].
The inclusion of enzymatic regulation in kinetic reconstructions can reveal
new optimization targets. This idea is also explored in [33] where the author
proposes an optimization method for kinetic models that not only adjusts the
enzyme expression levels but also the regulatory parameters. The method is
applied in a model of the central carbon metabolism of E. coli in order to
improve glucose uptake and serine synthesis.
5.4.3 Limitations and directions for improvement
In order to improve the simulation results it is important to find an appropri-
ate combination of rate laws and strategies for parameter estimation. Since
this is not the main focus of the work, we adopted GMA kinetics which is one
of the most simple formats. Default parameter values were used wherever
possible, and the rest were fitted to the steady-state flux distribution of the
original model.
One interesting remark is that the simulation results were reasonably
accurate in most cases although we have used default values for several pa-
rameters. This indicates that although these models may not be able to ac-
curately simulate the transient behavior of the system, they are good enough
for steady-state prediction.
For the selection of the rate laws, convenience kinetics were also consid-
ered. They have a semi-mechanistic format, which gives a closer description
to the enzymatic mechanisms and accounts for enzyme saturation [31]. How-
ever, preliminary tests showed no evidence of significant improvement when
compared to GMA kinetics. This is likely due to the fact that it uses a higher
number of parameters and requires a more sophisticate strategy for parame-
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ter estimation. The lin-log format is also a strong candidate [55]. It is based
on a reference steady-state, and has the advantage that only the elasticity
coefficients need to be estimated if the wild-type steady-state is given. How-
ever, it is important to keep in mind that increasing the complexity of the
rate laws not only increases the number of parameters but also the compu-
tational cost of the simulations performed. This is an fundamental aspect to
consider in order to apply this approach at the genome scale.
Regarding parameter estimation, one hypothesis is to use time-course
fluxomic and metabolomic data if available, to find better estimates for the
activation and inhibition constants. It is also possible to search these param-
eters in databases such as BRENDA [45] and SABIO-RK [42] to use as initial
estimates. However, the computational cost of time-course fitting strategies
becomes problematic for large models.
Steady-state parameter fitting with fluxomic and metabolomic data may
become mandatory at the genome scale. However, since there are typically
many parameters per equation, there is an underdetermined solution space
for the parameters. The most suitable values can be found through non-
linear optimization. The objective functions and conditions should rely on
generalized biological principles. For instance, it has been observed that sub-
strate concentrations are typically above the KM values to optimize enzyme
efficiency [2], and that the enzyme concentrations are optimally distributed
along the metabolic pathways [25]. The stability and robustness of the system
at the solution point should also be a required condition in the formulation
of the problem [5, 33].
Methods such as the ensemble modeling approach [52] may also be suit-
able in these cases. Rather than fitting particular parameter values, we may
sample the parameter space, and iteratively refine the ensemble by comparing
the simulation results with given experimental data.
5.5 Conclusions
The creation of kinetic models at the genome scale is an important step
towards the whole-cell simulation goals of Systems Biology. Several recent
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efforts in this field are also addressing the integration of metabolic, regulatory
and signaling networks in order to account for the control that these exert
over the cellular metabolism [13, 48, 14, 30]. This work addressed the inte-
gration of another layer of control which comes from enzymatic regulation. In
fact, it has been shown that this kind of regulation precedes transcriptional
regulation in situations where an immediate response is required [37].
Accounting for enzymatic regulation in large-scale kinetic reconstructions
of metabolism yields more accurate descriptions of metabolic networks by
expressing interactions that would otherwise be unforeseen. Moreover, it
can reveal new sets of targets for strain optimization in biotechnological
applications.
The computational cost of performing simulations with kinetic models of
increasingly larger sizes may become a bottleneck in this kind of approaches.
Model reduction strategies will have an important role to solve this issue.
In previous work we suggested an approach for structural network reduction
prior to the kinetic inference process, in order to reduce the network size,
and consequently, the complexity of the generated models [32].
In this work we used a dynamic model of the central carbon metabolism
of E. coli as a case-study in order to validate our approach. In the future,
this will be applied to larger network sizes for which dynamic model re-
constructions are not available. However, the latest genome-scale metabolic
reconstructions [17] do not account for the enzymatic regulation interac-
tions. Therefore, it will be necessary to annotate these models with such
information, which can be obtained from databases such as EcoCyc [23] and
BRENDA [45], before generating the kinetic models.
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Chapter 6
Conclusions
The work developed during this thesis addressed the creation of a solid mod-
eling framework for metabolic networks that will facilitate the integration
with other kinds of networks, namely gene regulatory and signaling. The
bacterium Escherichia coli was used as our case-study as it is the most well
characterized model organism and an important microbe for biotechnological
production processes [4].
Ideally, one would immediately attempt to integrate the available gene
regulatory and metabolic reconstructions. However, there is no well-estab-
lished framework for this integration so far. Current integration approaches
are based on constraint-based methods which present several shortcomings
[2, 8]. Gene regulatory networks are usually modeled with boolean networks,
and the integration with constraint-based metabolic models involves trans-
lating these rules into constraints to be imposed in the solution space [5, 11].
However, such translation may not be trivial or intuitive.
A very thorough review on the modeling formalisms that have been used
in Systems Biology shows that Petri nets are a suitable candidate for the cre-
ation of a modeling framework that supports all kinds of biological networks.
It is a graphical and mathematically sound formalism, therefore simultane-
ously intuitive and highly expressive. The integration of gene regulatory and
metabolic networks can be attained by “gluing” together both networks with
activation and inhibition arcs, rather than adapting the regulatory rules to
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a reaction-based scheme.
There is a current separation of approaches in the modeling of metabolic
networks. On one hand, there are dynamic model reconstructions of central
pathways that include fully detailed and parameterized kinetic equations [1].
On the other hand, there are genome-scale models based on more abstract
representations that only account for stoichiometry and reversibility con-
straints [3]. We explored the gap between both formulations for the same
metabolic network, and concluded that it is possible to take advantage of
the availability of dynamic models, even if incomplete, to refine the solution
space of constraint-based models.
The modeling trade-off between size and detail is also present in gene
regulatory networks, where genome-scale models with abstract representation
(boolean) and small kinetic models coexist separately [7]. Therefore the
previous study may also be applied to this kind of networks, and consequently
to integrated regulatory and metabolic networks.
Given the limitations associated with the constraint-based modeling ap-
proach, different authors have proposed the automatic generation of kinetic
models based on stoichiometric reconstructions [12, 13, 6]. Considering that
stoichiometric models and dynamic models are essentially equivalent to dis-
crete and continuous Petri nets respectively, we implemented the kinetic
inference process within a Petri net framework as a transformation from dis-
crete to continuous Petri nets. The implementation of this procedure within
the same formalism provides an intuitive and straightforward approach.
One of the consequences of applying this procedure to genome-scale mod-
els is the complexity of the generated models which comprise hundreds or
even thousands of kinetic equations and parameters. The size of metabolic
networks is also well known to be problematic when performing metabolic
pathway analysis as the number of possible pathways suffers from combina-
torial explosion given a large number of reactions [10]. In order to reduce the
complexity of metabolic networks we implemented network transformation
methods within this framework that merge together biochemical reactions
by eliminating intermediate metabolites. These transformations can be ap-
plied prior to the kinetic inference process, hence reducing the complexity
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and number of parameters in the generated dynamic models.
The top-down construction of kinetic models based on the available ge-
nome-scale stoichiometric reconstructions is a promising approach for genome-
scale kinetic modeling. It allows for a straightforward incorporation of high-
throughput data from several omics, including proteomics, metabolomics and
fluxomics. However, the utilization of constraint-based models as a scaffold
for this process results in the generation of kinetic models that do not account
for enzymatic regulation. This kind of regulation is used by the metabolism
for self-control and acts on a faster time-scale when compared to transcrip-
tional regulation. We proposed the utilization of Extended Petri nets, that
include activation and inhibition arcs, as a suitable formalism to model this
kind of regulation, and as a better scaffold for the kinetic inference process.
Accounting for enzymatic regulation results in more realistic metabolic
models, and may reveal new manipulation targets for rational strain design.
Although there has been much focus in the integration of transcriptional
regulation into metabolic networks [2, 8, 11], it seemed more urgent to address
the integration of enzymatic regulation, has it is part of the metabolism
itself. Moreover, it has been shown that the control imposed by this kind
of regulation precedes transcriptional regulation in adaptive responses [9].
Nevertheless, the approach used to incorporate enzymatic regulation should
support the integration of transcriptional regulation with minor adaptation
efforts.
As more heterogeneous high-throughput data becomes available, the de-
mand for a whole-cell simulation framework increases. From a metabolic
engineering perspective, the integration of gene regulatory and metabolic
networks is an important step for the creation of better models for rational
strain design. Building genome-scale kinetic models presents several advan-
tages compared to the popular constraint-based approach, such as accounting
for enzymatic regulation and intracellular dynamics, and determining unique
steady-state phenotypes. It remains unclear how to integrate gene regulatory
networks with such models. One strong possibility is to similarly generate
kinetic regulatory models from their boolean representation, or alternatively,
to consider hybrid network representations that account for discrete and con-
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tinuous nodes. In either case, Petri nets (with all their extensions) present a
solid framework for such purpose.
The top-down and bottom-up approaches for building kinetic models may
converge by replacing the central pathways of the automatically generated
models with available dynamic reconstructions of these pathways. To cope
with the size and complexity of the generated models, network modularity
and hierarchy concepts will become even more important. The methods here
developed for lumping selected modules into macroscopic reactions can play
an important role, specially if one takes advantage of the well characterized
central pathways to create genome-scale models with a detailed core comple-
mented with lumped versions of secondary pathways.
Two aspects of our framework have not yet been explored in detail and
will require further emphasis in the future. The first concerns the selection of
the ideal set of intermediary nodes to be eliminated in the model reduction
methods. Considering that this step is performed prior to kinetic inference,
the criteria for selection should be based on topological properties. Further
studies could elucidate how the structural changes of the network reflect in
its dynamic properties. The second aspect involves the parameter estima-
tion after the kinetic inference process. The large number of parameters
in genome-scale kinetic reconstructions, and the genome-scale omics data
available mainly at steady-state, will require new methods for parameter es-
timation rather than the traditional time-course fitting. Working with sets
of parameter samples instead of unique values, and iteratively refining these
sets of samples, as in the ensemble modeling approach [14], may be a possible
direction to address this issue.
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